# Implementasi Use Case Imunisasi COVID-19
*Last Updated: 2024/05/05*

## A. Pendahuluan
<div style="margin-left: 30px;">
<p>
Imunisasi memiliki peran yang sangat penting dalam menangani pandemi COVID-19. Imunisasi COVID-19 secara umum bertujuan untuk:
<ol>
<li>Melindungi Kesehatan Individu: Imunisasi COVID-19 efektif dalam melindungi individu dari penyakit yang parah, komplikasi serius, dan risiko kematian akibat COVID-19. Dengan menerima imunisasi, individu dapat mengurangi risiko mereka terkena penyakit yang membutuhkan perawatan medis intensif dan mengalami dampak jangka panjang pada kesehatan mereka.</li>
<li>Mencegah Penyebaran Penyakit: Imunisasi COVID-19 membantu mencegah penyebaran virus SARS-CoV-2 yang menyebabkan COVID-19. Dengan mengurangi jumlah orang yang rentan terhadap infeksi, imunisasi membantu menghentikan rantai penularan dan memutus mata rantai penyebaran virus.</li>
<li>Melindungi Masyarakat: Imunisasi COVID-19 juga melindungi masyarakat secara keseluruhan. Ketika cukup banyak orang diimunisasi, tercipta kekebalan komunal atau herd immunity. Hal ini melibatkan perlindungan bagi mereka yang tidak dapat atau belum diimunisasi, seperti anak-anak yang belum memenuhi syarat untuk imunisasi atau orang dengan sistem kekebalan yang lemah. Herd immunity membantu membatasi penyebaran virus di komunitas dan melindungi kelompok rentan.</li>
</ol>
</p>

<p>Selain dari proses imunisasi itu sendiri, proses pelaporan data imunisasi yang menyertai juga tidak kalah penting. Dalam skala nasional, proses pelaporan dan juga pengumpulan data berperan penting dalam proses perencanaan logistik imunisasi yang berbasis data, proses monitoring dan evaluasi dari program imunisasi, proses pemantauan kejadian ikutan pasca imunisasi, dan juga sebagai dasar dari berbagai kegiatan pengembangan dan pengambilan keputusan berbasis data. Oleh karena itu, proses pelaporan data imunisasi yang tepat, akurat, dan cepat adalah suatu hal yang sangat penting. Untuk itu, proses integrasi dari data imunisasi dengan SATUSEHAT adalah salah satu proses dasar yang penting dalam kegiatan imunisasi COVID-19.</p>

<p>Petunjuk implementasi use case Imunisasi COVID-19 dibuat sebagai panduan teknis untuk fasilitas pelayanan kesehatan atau pengembang rekam medis elektronik lainnya dalam melakukan proses integrasi dan interoperabilitas di dalam SATUSEHAT Platform, khususnya informasi terkait imunisasi COVID-19. Petunjuk implementasi ini menjelaskan secara detail mengenai standar tahapan alur integrasi dan format pengiriman data, mulai dari:</p>
<ol>
<li>Pendaftaran Pasien</li>
<li>Pendaftaran Kunjungan</li>
<li>Skrining Imunisasi COVID-19</li>
<li>Pencatatan Imunisasi COVID-19</li>
<li>Pencatatan Gejala KIPI</li>
<li>Pencatatan Diagnosis</li>
<li>Pencatatan Tindakan/Prosedur Medis</li>
<li>Pembaharuan Data Kunjungan</li>
</ol>

Resource FHIR yang digunakan pada use case ini yaitu:
<style>

.table-fhir-resources {
    border-collapse: collapse;
}

.table-scroll {
    display: block;
    overflow: scroll;
    height: 50%;
}

.table-fhir-resources, .table-fhir-resources th, .table-fhir-resources td {
   border: 1px solid black;
}

.table-fhir-resources th, .table-fhir-resources td {
   padding: 5px;
}
</style>

<table class="table-fhir-resources">
<tr>
	<th>Category</th>
	<th>No</th>
	<th>Resource</th>
	<th>Entry Mandatory</th>
</tr>
<tr>
	<td rowspan="5">Base</td>
	<td>1</td>
	<td>Patient</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>2</td>
	<td>Practitioner</td>
	<td><b>Required</b></td>
</tr>

<tr>
	<td>3</td>
	<td>Organization</td>
	<td><b>Required</b></td>
</tr>

<tr>
	<td>4</td>
	<td>Location</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>5</td>
	<td>Encounter</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td rowspan="8">Clinical</td>
	<td>6</td>
	<td>Condition</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>7</td>
	<td>Immunization</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>8</td>
	<td>Observation</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>9</td>
	<td>Procedure</td>
	<td><b>Required</b></td>
</tr>
<tr>
	<td>10</td>
	<td>QuestionnaireResponse</td>
	<td><b>Required</b></td>
</tr>
</table>

<br>_Notes:_<br>
1. __Required__: Entry resource harus dilibatkan setiap kali mengirimkan bundle
2. _Optional_: Entry resource dapat tidak dilibatkan setiap kali mengirimkan bundle
</div>

<p>Tahapan alur integrasi dan resource yang digunakan untuk integrasi pelaporan imunisasi COVID-19 dapat dilihat pada Gambar 3.</p>

<center>
{{render:covid-vaksin-vaksin-skema}}

*Gambar 1. Alur Integrasi Imunisasi COVID-19*
</center>

## Referensi:

<table style="background-color: #f6f8f8; border-radius: 10px;">
	<tr>
		<td style="padding: 10px 20px; width: 33%; vertical-align: top;">Postman Vaksinasi COVID-19</td>
		<td style="padding: 10px 20px; ; width: 33%; vertical-align: top;">Playbook Vaksinasi COVID-19 </td>
		<td style="padding: 10px 20px; ; width: 33%; vertical-align: top;">Postman Resume Medis Rawat Jalan SATUSEHAT</td>
	</tr>
	<tr>
		<td style="padding: 10px 20px; ;">
			<div style="background-color: lightblue; display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,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');" onclick="window.open('https://drive.google.com/file/d/10toxyWErjBKpB4-j4JILqfHwGAiPXyki/view?usp=drive_link', '_blank');"/>
		</td>
		<td style="padding: 10px 20px; ;">
			<div style="display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" width="125" zoomAndPan="magnify" viewBox="0 0 93.75 30.000001" height="40" preserveAspectRatio="xMidYMid meet" version="1.0"><defs><g/><clipPath id="a7d2e34f6a"><path d="M 1.957031 1.246094 L 91.96875 1.246094 L 91.96875 23.878906 L 1.957031 23.878906 Z M 1.957031 1.246094 " clip-rule="nonzero"/></clipPath><clipPath id="70ab78da36"><path d="M 4.140625 1.246094 L 89.609375 1.246094 C 90.816406 1.246094 91.792969 2.222656 91.792969 3.429688 L 91.792969 21.519531 C 91.792969 22.726562 90.816406 23.703125 89.609375 23.703125 L 4.140625 23.703125 C 2.933594 23.703125 1.957031 22.726562 1.957031 21.519531 L 1.957031 3.429688 C 1.957031 2.222656 2.933594 1.246094 4.140625 1.246094 " clip-rule="nonzero"/></clipPath><clipPath id="37809d1fea"><path d="M 16.113281 7.207031 L 17.957031 7.207031 L 17.957031 9.027344 L 16.113281 9.027344 Z M 16.113281 7.207031 " clip-rule="nonzero"/></clipPath><clipPath id="345c01d24f"><path d="M 10.679688 7.199219 L 17.957031 7.199219 L 17.957031 17.390625 L 10.679688 17.390625 Z M 10.679688 7.199219 " clip-rule="nonzero"/></clipPath></defs><g clip-path="url(#a7d2e34f6a)"><g clip-path="url(#70ab78da36)"><path fill="#47b08b" d="M 1.957031 1.246094 L 91.96875 1.246094 L 91.96875 23.878906 L 1.957031 23.878906 Z M 1.957031 1.246094 " fill-opacity="1" fill-rule="nonzero"/></g></g><g clip-path="url(#37809d1fea)"><path fill="#ffffff" d="M 16.136719 7.207031 L 16.199219 7.207031 L 16.273438 7.234375 L 16.351562 7.265625 L 17.890625 8.765625 L 17.957031 8.828125 L 17.957031 9.007812 L 16.136719 9.007812 L 16.136719 7.207031 " fill-opacity="1" fill-rule="evenodd"/></g><g clip-path="url(#345c01d24f)"><path fill="#ffffff" d="M 10.890625 7.207031 L 15.921875 7.207031 L 15.921875 9.21875 L 17.957031 9.21875 L 17.957031 17.386719 L 10.679688 17.386719 L 10.679688 7.207031 Z M 12.554688 9.550781 C 12.023438 9.875 11.679688 10.382812 11.546875 10.9375 C 11.414062 11.496094 11.496094 12.101562 11.824219 12.625 C 12.152344 13.152344 12.664062 13.496094 13.226562 13.625 C 13.628906 13.71875 14.054688 13.703125 14.457031 13.570312 L 16.09375 16.183594 C 16.160156 16.292969 16.257812 16.371094 16.359375 16.414062 C 16.484375 16.464844 16.621094 16.464844 16.734375 16.394531 L 16.882812 16.304688 C 16.996094 16.234375 17.058594 16.113281 17.066406 15.980469 C 17.074219 15.871094 17.042969 15.75 16.976562 15.640625 L 15.339844 13.027344 C 15.640625 12.726562 15.84375 12.355469 15.9375 11.960938 C 16.070312 11.402344 15.988281 10.796875 15.660156 10.273438 C 15.332031 9.746094 14.820312 9.402344 14.257812 9.273438 C 13.695312 9.144531 13.082031 9.226562 12.554688 9.550781 Z M 14.421875 13.132812 L 14.460938 13.113281 C 14.496094 13.101562 14.527344 13.085938 14.554688 13.074219 L 14.554688 13.070312 C 14.566406 13.066406 14.574219 13.0625 14.585938 13.054688 C 14.625 13.035156 14.660156 13.015625 14.691406 12.996094 C 14.695312 12.996094 14.699219 12.992188 14.707031 12.988281 C 14.757812 12.957031 14.808594 12.921875 14.855469 12.886719 C 14.878906 12.867188 14.902344 12.847656 14.925781 12.828125 L 14.953125 12.804688 C 15.242188 12.554688 15.4375 12.222656 15.523438 11.863281 C 15.628906 11.410156 15.5625 10.917969 15.296875 10.496094 C 15.03125 10.070312 14.617188 9.792969 14.160156 9.6875 C 13.703125 9.582031 13.207031 9.644531 12.777344 9.910156 C 12.351562 10.171875 12.070312 10.582031 11.960938 11.035156 C 11.855469 11.488281 11.921875 11.980469 12.1875 12.402344 C 12.453125 12.828125 12.867188 13.105469 13.324219 13.210938 C 13.683594 13.296875 14.066406 13.273438 14.421875 13.132812 " fill-opacity="1" fill-rule="evenodd"/></g><path fill="#212121" d="M 16.507812 16.035156 L 16.523438 16.023438 C 16.523438 16.023438 16.496094 16.042969 16.507812 16.035156 " fill-opacity="1" fill-rule="nonzero"/><path fill="#212121" d="M 16.65625 15.945312 C 16.667969 15.9375 16.640625 15.953125 16.640625 15.953125 L 16.65625 15.945312 " fill-opacity="1" fill-rule="nonzero"/><g fill="#ffffff" fill-opacity="1"><g transform="translate(21.594829, 15.960062)"><g><path d="M 6.390625 -6.515625 L 3.765625 0 L 2.546875 0 L -0.078125 -6.515625 L 1 -6.515625 C 1.125 -6.515625 1.222656 -6.488281 1.296875 -6.4375 C 1.367188 -6.382812 1.421875 -6.3125 1.453125 -6.21875 L 2.859375 -2.46875 C 2.921875 -2.320312 2.976562 -2.164062 3.03125 -2 C 3.082031 -1.832031 3.128906 -1.660156 3.171875 -1.484375 C 3.210938 -1.660156 3.253906 -1.832031 3.296875 -2 C 3.347656 -2.164062 3.398438 -2.320312 3.453125 -2.46875 L 4.859375 -6.21875 C 4.878906 -6.289062 4.925781 -6.359375 5 -6.421875 C 5.082031 -6.484375 5.179688 -6.515625 5.296875 -6.515625 Z M 6.390625 -6.515625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(27.901463, 15.960062)"><g><path d="M 1.78125 -4.625 L 1.78125 0 L 0.546875 0 L 0.546875 -4.625 Z M 1.9375 -5.953125 C 1.9375 -5.847656 1.914062 -5.75 1.875 -5.65625 C 1.832031 -5.5625 1.773438 -5.476562 1.703125 -5.40625 C 1.628906 -5.34375 1.546875 -5.289062 1.453125 -5.25 C 1.359375 -5.21875 1.257812 -5.203125 1.15625 -5.203125 C 1.050781 -5.203125 0.953125 -5.21875 0.859375 -5.25 C 0.773438 -5.289062 0.695312 -5.34375 0.625 -5.40625 C 0.550781 -5.476562 0.492188 -5.5625 0.453125 -5.65625 C 0.421875 -5.75 0.40625 -5.847656 0.40625 -5.953125 C 0.40625 -6.054688 0.421875 -6.148438 0.453125 -6.234375 C 0.492188 -6.328125 0.550781 -6.40625 0.625 -6.46875 C 0.695312 -6.539062 0.773438 -6.597656 0.859375 -6.640625 C 0.953125 -6.679688 1.050781 -6.703125 1.15625 -6.703125 C 1.257812 -6.703125 1.359375 -6.679688 1.453125 -6.640625 C 1.546875 -6.597656 1.628906 -6.539062 1.703125 -6.46875 C 1.773438 -6.40625 1.832031 -6.328125 1.875 -6.234375 C 1.914062 -6.148438 1.9375 -6.054688 1.9375 -5.953125 Z M 1.9375 -5.953125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(30.237254, 15.960062)"><g><path d="M 3.453125 -2.859375 C 3.453125 -2.992188 3.429688 -3.117188 3.390625 -3.234375 C 3.359375 -3.347656 3.304688 -3.445312 3.234375 -3.53125 C 3.160156 -3.625 3.066406 -3.695312 2.953125 -3.75 C 2.835938 -3.800781 2.703125 -3.828125 2.546875 -3.828125 C 2.242188 -3.828125 2.007812 -3.742188 1.84375 -3.578125 C 1.675781 -3.410156 1.566406 -3.171875 1.515625 -2.859375 Z M 1.5 -2.125 C 1.539062 -1.6875 1.664062 -1.367188 1.875 -1.171875 C 2.082031 -0.972656 2.351562 -0.875 2.6875 -0.875 C 2.851562 -0.875 3 -0.894531 3.125 -0.9375 C 3.25 -0.976562 3.359375 -1.019531 3.453125 -1.0625 C 3.546875 -1.113281 3.628906 -1.160156 3.703125 -1.203125 C 3.785156 -1.242188 3.863281 -1.265625 3.9375 -1.265625 C 4.03125 -1.265625 4.109375 -1.226562 4.171875 -1.15625 L 4.53125 -0.703125 C 4.394531 -0.546875 4.242188 -0.414062 4.078125 -0.3125 C 3.921875 -0.21875 3.757812 -0.140625 3.59375 -0.078125 C 3.425781 -0.0234375 3.253906 0.0078125 3.078125 0.03125 C 2.898438 0.0507812 2.734375 0.0625 2.578125 0.0625 C 2.253906 0.0625 1.953125 0.0078125 1.671875 -0.09375 C 1.390625 -0.195312 1.144531 -0.351562 0.9375 -0.5625 C 0.726562 -0.769531 0.5625 -1.023438 0.4375 -1.328125 C 0.320312 -1.640625 0.265625 -2 0.265625 -2.40625 C 0.265625 -2.726562 0.316406 -3.023438 0.421875 -3.296875 C 0.523438 -3.578125 0.671875 -3.820312 0.859375 -4.03125 C 1.054688 -4.238281 1.296875 -4.398438 1.578125 -4.515625 C 1.859375 -4.640625 2.171875 -4.703125 2.515625 -4.703125 C 2.816406 -4.703125 3.09375 -4.65625 3.34375 -4.5625 C 3.59375 -4.46875 3.804688 -4.328125 3.984375 -4.140625 C 4.171875 -3.960938 4.3125 -3.742188 4.40625 -3.484375 C 4.507812 -3.222656 4.5625 -2.925781 4.5625 -2.59375 C 4.5625 -2.5 4.554688 -2.421875 4.546875 -2.359375 C 4.535156 -2.296875 4.519531 -2.25 4.5 -2.21875 C 4.476562 -2.1875 4.445312 -2.160156 4.40625 -2.140625 C 4.375 -2.128906 4.332031 -2.125 4.28125 -2.125 Z M 1.5 -2.125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(35.052576, 15.960062)"><g><path d="M 7.21875 -4.625 L 5.765625 0 L 4.765625 0 C 4.710938 0 4.664062 -0.015625 4.625 -0.046875 C 4.582031 -0.078125 4.550781 -0.132812 4.53125 -0.21875 L 3.78125 -2.71875 C 3.75 -2.8125 3.722656 -2.90625 3.703125 -3 C 3.679688 -3.101562 3.660156 -3.203125 3.640625 -3.296875 C 3.617188 -3.203125 3.597656 -3.101562 3.578125 -3 C 3.554688 -2.90625 3.53125 -2.8125 3.5 -2.71875 L 2.734375 -0.21875 C 2.691406 -0.0703125 2.601562 0 2.46875 0 L 1.515625 0 L 0.046875 -4.625 L 1.046875 -4.625 C 1.128906 -4.625 1.203125 -4.601562 1.265625 -4.5625 C 1.328125 -4.519531 1.367188 -4.46875 1.390625 -4.40625 L 1.96875 -2.109375 C 2 -1.960938 2.023438 -1.820312 2.046875 -1.6875 C 2.078125 -1.550781 2.109375 -1.414062 2.140625 -1.28125 C 2.171875 -1.414062 2.207031 -1.550781 2.25 -1.6875 C 2.289062 -1.820312 2.332031 -1.960938 2.375 -2.109375 L 3.0625 -4.421875 C 3.082031 -4.484375 3.117188 -4.535156 3.171875 -4.578125 C 3.234375 -4.617188 3.304688 -4.640625 3.390625 -4.640625 L 3.9375 -4.640625 C 4.019531 -4.640625 4.09375 -4.617188 4.15625 -4.578125 C 4.21875 -4.535156 4.257812 -4.484375 4.28125 -4.421875 L 4.9375 -2.109375 C 4.976562 -1.972656 5.015625 -1.832031 5.046875 -1.6875 C 5.085938 -1.550781 5.128906 -1.410156 5.171875 -1.265625 C 5.191406 -1.410156 5.210938 -1.550781 5.234375 -1.6875 C 5.265625 -1.820312 5.300781 -1.960938 5.34375 -2.109375 L 5.9375 -4.40625 C 5.957031 -4.46875 6 -4.519531 6.0625 -4.5625 C 6.125 -4.601562 6.195312 -4.625 6.28125 -4.625 Z M 7.21875 -4.625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(42.324968, 15.960062)"><g/></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(44.458624, 15.960062)"><g><path d="M 2.890625 -3.28125 C 3.304688 -3.28125 3.613281 -3.378906 3.8125 -3.578125 C 4.007812 -3.785156 4.109375 -4.066406 4.109375 -4.421875 C 4.109375 -4.578125 4.082031 -4.722656 4.03125 -4.859375 C 3.976562 -4.992188 3.898438 -5.109375 3.796875 -5.203125 C 3.703125 -5.296875 3.578125 -5.367188 3.421875 -5.421875 C 3.273438 -5.472656 3.097656 -5.5 2.890625 -5.5 L 2.03125 -5.5 L 2.03125 -3.28125 Z M 2.890625 -6.515625 C 3.328125 -6.515625 3.707031 -6.460938 4.03125 -6.359375 C 4.363281 -6.253906 4.632812 -6.109375 4.84375 -5.921875 C 5.050781 -5.734375 5.203125 -5.507812 5.296875 -5.25 C 5.398438 -5 5.453125 -4.722656 5.453125 -4.421875 C 5.453125 -4.097656 5.398438 -3.800781 5.296875 -3.53125 C 5.191406 -3.269531 5.03125 -3.039062 4.8125 -2.84375 C 4.601562 -2.65625 4.335938 -2.503906 4.015625 -2.390625 C 3.691406 -2.285156 3.316406 -2.234375 2.890625 -2.234375 L 2.03125 -2.234375 L 2.03125 0 L 0.6875 0 L 0.6875 -6.515625 Z M 2.890625 -6.515625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(50.091471, 15.960062)"><g><path d="M 1.765625 -6.703125 L 1.765625 0 L 0.515625 0 L 0.515625 -6.703125 Z M 1.765625 -6.703125 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(52.373359, 15.960062)"><g><path d="M 2.9375 -1.9375 C 2.632812 -1.914062 2.378906 -1.882812 2.171875 -1.84375 C 1.972656 -1.8125 1.8125 -1.765625 1.6875 -1.703125 C 1.570312 -1.648438 1.488281 -1.582031 1.4375 -1.5 C 1.394531 -1.425781 1.375 -1.347656 1.375 -1.265625 C 1.375 -1.078125 1.421875 -0.945312 1.515625 -0.875 C 1.617188 -0.800781 1.757812 -0.765625 1.9375 -0.765625 C 2.144531 -0.765625 2.320312 -0.800781 2.46875 -0.875 C 2.625 -0.945312 2.78125 -1.0625 2.9375 -1.21875 Z M 0.40625 -3.984375 C 0.675781 -4.234375 0.976562 -4.414062 1.3125 -4.53125 C 1.644531 -4.65625 2 -4.71875 2.375 -4.71875 C 2.65625 -4.71875 2.90625 -4.671875 3.125 -4.578125 C 3.34375 -4.492188 3.523438 -4.367188 3.671875 -4.203125 C 3.828125 -4.046875 3.941406 -3.859375 4.015625 -3.640625 C 4.097656 -3.421875 4.140625 -3.175781 4.140625 -2.90625 L 4.140625 0 L 3.578125 0 C 3.460938 0 3.375 -0.015625 3.3125 -0.046875 C 3.25 -0.078125 3.195312 -0.144531 3.15625 -0.25 L 3.0625 -0.546875 C 2.945312 -0.453125 2.832031 -0.363281 2.71875 -0.28125 C 2.613281 -0.207031 2.5 -0.144531 2.375 -0.09375 C 2.257812 -0.0390625 2.132812 0 2 0.03125 C 1.875 0.0625 1.726562 0.078125 1.5625 0.078125 C 1.351562 0.078125 1.164062 0.0507812 1 0 C 0.832031 -0.0625 0.6875 -0.144531 0.5625 -0.25 C 0.445312 -0.351562 0.351562 -0.484375 0.28125 -0.640625 C 0.21875 -0.804688 0.1875 -0.988281 0.1875 -1.1875 C 0.1875 -1.363281 0.226562 -1.535156 0.3125 -1.703125 C 0.40625 -1.878906 0.554688 -2.035156 0.765625 -2.171875 C 0.972656 -2.304688 1.253906 -2.421875 1.609375 -2.515625 C 1.960938 -2.609375 2.40625 -2.660156 2.9375 -2.671875 L 2.9375 -2.90625 C 2.9375 -3.195312 2.875 -3.410156 2.75 -3.546875 C 2.625 -3.679688 2.445312 -3.75 2.21875 -3.75 C 2.050781 -3.75 1.910156 -3.726562 1.796875 -3.6875 C 1.679688 -3.65625 1.578125 -3.613281 1.484375 -3.5625 C 1.398438 -3.519531 1.320312 -3.476562 1.25 -3.4375 C 1.175781 -3.394531 1.09375 -3.375 1 -3.375 C 0.90625 -3.375 0.828125 -3.394531 0.765625 -3.4375 C 0.710938 -3.476562 0.664062 -3.53125 0.625 -3.59375 Z M 0.40625 -3.984375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(56.973069, 15.960062)"><g><path d="M 4.8125 -4.625 L 2.3125 1.25 C 2.269531 1.332031 2.21875 1.394531 2.15625 1.4375 C 2.101562 1.476562 2.019531 1.5 1.90625 1.5 L 0.984375 1.5 L 1.859375 -0.375 L 0 -4.625 L 1.09375 -4.625 C 1.1875 -4.625 1.257812 -4.601562 1.3125 -4.5625 C 1.363281 -4.519531 1.40625 -4.46875 1.4375 -4.40625 L 2.3125 -2.1875 C 2.34375 -2.101562 2.367188 -2.015625 2.390625 -1.921875 C 2.421875 -1.835938 2.445312 -1.753906 2.46875 -1.671875 C 2.53125 -1.847656 2.59375 -2.023438 2.65625 -2.203125 L 3.484375 -4.40625 C 3.503906 -4.46875 3.546875 -4.519531 3.609375 -4.5625 C 3.671875 -4.601562 3.738281 -4.625 3.8125 -4.625 Z M 4.8125 -4.625 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(61.752453, 15.960062)"><g><path d="M 1.75 -1.21875 C 1.863281 -1.082031 1.988281 -0.988281 2.125 -0.9375 C 2.269531 -0.882812 2.414062 -0.859375 2.5625 -0.859375 C 2.707031 -0.859375 2.84375 -0.882812 2.96875 -0.9375 C 3.09375 -1 3.195312 -1.085938 3.28125 -1.203125 C 3.375 -1.328125 3.445312 -1.484375 3.5 -1.671875 C 3.550781 -1.867188 3.578125 -2.109375 3.578125 -2.390625 C 3.578125 -2.628906 3.554688 -2.832031 3.515625 -3 C 3.472656 -3.175781 3.410156 -3.320312 3.328125 -3.4375 C 3.253906 -3.550781 3.160156 -3.628906 3.046875 -3.671875 C 2.941406 -3.722656 2.816406 -3.75 2.671875 -3.75 C 2.472656 -3.75 2.300781 -3.707031 2.15625 -3.625 C 2.019531 -3.539062 1.882812 -3.414062 1.75 -3.25 Z M 1.75 -4.09375 C 1.9375 -4.28125 2.140625 -4.425781 2.359375 -4.53125 C 2.578125 -4.644531 2.828125 -4.703125 3.109375 -4.703125 C 3.367188 -4.703125 3.601562 -4.648438 3.8125 -4.546875 C 4.03125 -4.441406 4.210938 -4.289062 4.359375 -4.09375 C 4.515625 -3.894531 4.632812 -3.65625 4.71875 -3.375 C 4.800781 -3.09375 4.84375 -2.78125 4.84375 -2.4375 C 4.84375 -2.0625 4.796875 -1.71875 4.703125 -1.40625 C 4.609375 -1.101562 4.472656 -0.84375 4.296875 -0.625 C 4.128906 -0.40625 3.921875 -0.234375 3.671875 -0.109375 C 3.429688 0.00390625 3.164062 0.0625 2.875 0.0625 C 2.726562 0.0625 2.597656 0.046875 2.484375 0.015625 C 2.367188 -0.00390625 2.265625 -0.0390625 2.171875 -0.09375 C 2.078125 -0.144531 1.988281 -0.203125 1.90625 -0.265625 C 1.820312 -0.335938 1.75 -0.421875 1.6875 -0.515625 L 1.625 -0.234375 C 1.601562 -0.148438 1.566406 -0.0859375 1.515625 -0.046875 C 1.472656 -0.015625 1.410156 0 1.328125 0 L 0.515625 0 L 0.515625 -6.703125 L 1.75 -6.703125 Z M 1.75 -4.09375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(66.882206, 15.960062)"><g><path d="M 2.59375 -4.703125 C 2.945312 -4.703125 3.265625 -4.644531 3.546875 -4.53125 C 3.828125 -4.425781 4.070312 -4.269531 4.28125 -4.0625 C 4.488281 -3.851562 4.644531 -3.601562 4.75 -3.3125 C 4.863281 -3.019531 4.921875 -2.691406 4.921875 -2.328125 C 4.921875 -1.953125 4.863281 -1.617188 4.75 -1.328125 C 4.644531 -1.035156 4.488281 -0.785156 4.28125 -0.578125 C 4.070312 -0.367188 3.828125 -0.207031 3.546875 -0.09375 C 3.265625 0.0078125 2.945312 0.0625 2.59375 0.0625 C 2.25 0.0625 1.929688 0.0078125 1.640625 -0.09375 C 1.359375 -0.207031 1.113281 -0.367188 0.90625 -0.578125 C 0.707031 -0.785156 0.550781 -1.035156 0.4375 -1.328125 C 0.320312 -1.617188 0.265625 -1.953125 0.265625 -2.328125 C 0.265625 -2.691406 0.320312 -3.019531 0.4375 -3.3125 C 0.550781 -3.601562 0.707031 -3.851562 0.90625 -4.0625 C 1.113281 -4.269531 1.359375 -4.425781 1.640625 -4.53125 C 1.929688 -4.644531 2.25 -4.703125 2.59375 -4.703125 Z M 2.59375 -0.859375 C 2.945312 -0.859375 3.207031 -0.976562 3.375 -1.21875 C 3.550781 -1.46875 3.640625 -1.832031 3.640625 -2.3125 C 3.640625 -2.789062 3.550781 -3.148438 3.375 -3.390625 C 3.207031 -3.640625 2.945312 -3.765625 2.59375 -3.765625 C 2.238281 -3.765625 1.972656 -3.640625 1.796875 -3.390625 C 1.628906 -3.148438 1.546875 -2.789062 1.546875 -2.3125 C 1.546875 -1.832031 1.628906 -1.46875 1.796875 -1.21875 C 1.972656 -0.976562 2.238281 -0.859375 2.59375 -0.859375 Z M 2.59375 -0.859375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(72.070356, 15.960062)"><g><path d="M 2.59375 -4.703125 C 2.945312 -4.703125 3.265625 -4.644531 3.546875 -4.53125 C 3.828125 -4.425781 4.070312 -4.269531 4.28125 -4.0625 C 4.488281 -3.851562 4.644531 -3.601562 4.75 -3.3125 C 4.863281 -3.019531 4.921875 -2.691406 4.921875 -2.328125 C 4.921875 -1.953125 4.863281 -1.617188 4.75 -1.328125 C 4.644531 -1.035156 4.488281 -0.785156 4.28125 -0.578125 C 4.070312 -0.367188 3.828125 -0.207031 3.546875 -0.09375 C 3.265625 0.0078125 2.945312 0.0625 2.59375 0.0625 C 2.25 0.0625 1.929688 0.0078125 1.640625 -0.09375 C 1.359375 -0.207031 1.113281 -0.367188 0.90625 -0.578125 C 0.707031 -0.785156 0.550781 -1.035156 0.4375 -1.328125 C 0.320312 -1.617188 0.265625 -1.953125 0.265625 -2.328125 C 0.265625 -2.691406 0.320312 -3.019531 0.4375 -3.3125 C 0.550781 -3.601562 0.707031 -3.851562 0.90625 -4.0625 C 1.113281 -4.269531 1.359375 -4.425781 1.640625 -4.53125 C 1.929688 -4.644531 2.25 -4.703125 2.59375 -4.703125 Z M 2.59375 -0.859375 C 2.945312 -0.859375 3.207031 -0.976562 3.375 -1.21875 C 3.550781 -1.46875 3.640625 -1.832031 3.640625 -2.3125 C 3.640625 -2.789062 3.550781 -3.148438 3.375 -3.390625 C 3.207031 -3.640625 2.945312 -3.765625 2.59375 -3.765625 C 2.238281 -3.765625 1.972656 -3.640625 1.796875 -3.390625 C 1.628906 -3.148438 1.546875 -2.789062 1.546875 -2.3125 C 1.546875 -1.832031 1.628906 -1.46875 1.796875 -1.21875 C 1.972656 -0.976562 2.238281 -0.859375 2.59375 -0.859375 Z M 2.59375 -0.859375 "/></g></g></g><g fill="#ffffff" fill-opacity="1"><g transform="translate(77.258506, 15.960062)"><g><path d="M 1.75 -6.703125 L 1.75 -2.890625 L 1.953125 -2.890625 C 2.035156 -2.890625 2.097656 -2.898438 2.140625 -2.921875 C 2.179688 -2.953125 2.226562 -3 2.28125 -3.0625 L 3.296875 -4.421875 C 3.347656 -4.492188 3.40625 -4.546875 3.46875 -4.578125 C 3.539062 -4.609375 3.625 -4.625 3.71875 -4.625 L 4.859375 -4.625 L 3.515625 -2.9375 C 3.410156 -2.800781 3.289062 -2.691406 3.15625 -2.609375 C 3.226562 -2.554688 3.289062 -2.5 3.34375 -2.4375 C 3.394531 -2.375 3.441406 -2.304688 3.484375 -2.234375 L 4.921875 0 L 3.8125 0 C 3.707031 0 3.617188 -0.015625 3.546875 -0.046875 C 3.484375 -0.078125 3.429688 -0.132812 3.390625 -0.21875 L 2.34375 -1.921875 C 2.300781 -1.992188 2.253906 -2.039062 2.203125 -2.0625 C 2.160156 -2.082031 2.097656 -2.09375 2.015625 -2.09375 L 1.75 -2.09375 L 1.75 0 L 0.515625 0 L 0.515625 -6.703125 Z M 1.75 -6.703125 "/></g></g></g></svg>');" onclick="window.open('https://drive.google.com/file/d/1j50r_6WJnAsZh7rYJbjWGvd1f1K6hYHk/view?usp=sharing', '_blank');"/>
		</td>
		<td style="padding: 10px 20px;">
			<div style="background-color: lightblue; display: inline-block; border-radius: 4px; cursor: pointer; height: 32px; border: none; width: 123px; background-image: url('data:image/svg+xml;base64,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');" onclick="window.open('https://www.postman.com/satusehat/workspace/satusehat-public/overview', '_blank');"/>
		</td>
	</tr>
</table>

## B. Strategi Pengiriman Data ke SATUSEHAT
<div style="margin-left: 30px;">
SATUSEHAT menyediakan dua pilihan cara mengirimkan data use case vaksinasi COVID-19:

### 1. Berbasis Resource
Data dapat dikirimkan secara berurutan sesuai resource yang terlibat pada alur pelayanan terkait. Sebagai contoh: ketika mengirimkan data registrasi kunjungan saja yang berisikan resource Encounter dan QuestionnaireResponse, maka implementor mengirimkan resource-resource tersebut ke SATUSEHAT secara berurutan sesuai dependensinya.

### 2. Berbasis Bundle
Data dapat dikirimkan seluruh resource yang terlibat pada alur pelayanan terkait dengan menggunakan satu langkah pengiriman data ke SATUSEHAT menggunakan profil FHIR bernama Bundle.
</div>

## C. Langkah-Langkah Pengiriman Data ke SATUSEHAT

<div style="margin-left: 30px;">

### <b>Informasi Variabel</b>

<p>Variabel serta pemetaan terhadap resource FHIR untuk Pelaporan Vaksinasi COVID-19  yang dipertukarkan dapat dilihat dalam tabel berikut.</p>

<table class="table-fhir-resources table-scroll">
	<tr>
		<th>No</th>
		<th colspan="2">Variabel</th>
		<th>Resource FHIR</th>
		<th>Path FHIR</th>
	</tr>
	<tr>
		<td>1</td>
		<td colspan="4">Verifikasi Data Identitas</td>
	</tr>
	<tr>
		<td rowspan="13"/>
		<td rowspan="3">a</td>
		<td rowspan="3">Nomor SATUSEHAT Pasien</td>
		<td rowspan="3">Patient</td>
		<td>Patient.identifier[i].use</td>
	</tr>
	<tr>
		<td>Patient.identifier[i].system</td>
	</tr>
	<tr>
		<td>Patient.identifier[i].value</td>
	</tr>
	<tr>
		<td>b</td>
		<td>Nama Lengkap</td>
		<td>Patient</td>
		<td>Patient.name[i].text </td>
	</tr>
	<tr>
		<td rowspan="3">c</td>
		<td rowspan="3">Nomor Induk Kependudukan (NIK)</td>
		<td rowspan="3">Patient</td>
		<td>Patient.identifier[i].use</td>
	</tr>
	<tr>
		<td>Patient.identifier[i].system</td>
	</tr>
	<tr>
		<td>Patient.identifier[i].value</td>
	</tr>
	<tr>
		<td>d</td>
		<td>Tanggal Lahir</td>
		<td>Patient</td>
		<td>Patient.birthDate</td>
	</tr>
	<tr>
		<td>e</td>
		<td>Jenis Kelamin</td>
		<td>Patient</td>
		<td>Patient.gender</td>
	</tr>
	<tr>
		<td>f</td>
		<td>Alamat Lengkap</td>
		<td>Patient</td>
		<td>Patient.address.line</td>
	</tr>
	<tr>
		<td>g</td>
		<td>Nomor HP</td>
		<td>Patient</td>
		<td>Patient.contact.telecom.value</td>
	</tr>
	<tr>
		<td>h</td>
		<td>Dosis terakhir imunisasi COVID-19 yang didapatkan</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueString</td>
	</tr>
	<tr>
		<td>i</td>
		<td>Kapan terakhir kali menerima imunisasi COVID-19?</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueDate</td>
	</tr>
	<tr>
		<td>2</td>
		<td class="c222" colspan="4">Data Kunjungan</td>
	</tr>
	<tr>
		<td rowspan="6"/>
		<td>a</td>
		<td>Tanggal &amp; Jam Masuk (Tanggal Kunjungan)</td>
		<td>Encounter</td>
		<td>Encounter.period.start</td>
	</tr>
	<tr>
		<td>b</td>
		<td>Tanggal &amp; Jam Discharge Administrasi</td>
		<td>Encounter</td>
		<td>Encounter.period.end</td>
	</tr>
	<tr>
		<td rowspan="2">c</td>
		<td rowspan="2">Tenaga Kesehatan</td>
		<td rowspan="2">Encounter</td>
		<td>Encounter.participant</td>
	</tr>
	<tr>
		<td>Encounter.participant.type</td>
	</tr>
	<tr>
		<td>d</td>
		<td>Lokasi kunjungan</td>
		<td>Encounter</td>
		<td>Encounter.location</td>
	</tr>
	<tr>
		<td>e</td>
		<td>Fasilitas Kesehatan</td>
		<td>Encounter</td>
		<td>Encounter.serviceProvider</td>
	</tr>
	<tr>
		<td>3</td>
		<td class="c222" colspan="4">Penentuan Sasaran</td>
	</tr>
	<tr>
		<td rowspan="9"/>
		<td>a</td>
		<td>Usia</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueCoding</td>
	</tr>
	<tr>
		<td>b</td>
		<td>Ibu Hamil</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueBoolean</td>
	</tr>
	<tr>
		<td>c</td>
		<td>Tenaga Kesehatan</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueBoolean</td>
	</tr>
	<tr>
		<td>d</td>
		<td>Apakah Anda memiliki penyakit komorbid (jawaban boleh lebih dari satu)</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueCoding</td>
	</tr>
	<tr>
		<td>e</td>
		<td>Apakah Anda memiliki immunocompromised (jawaban boleh lebih dari satu)</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueCoding</td>
	</tr>
	<tr>
		<td rowspan="4">f</td>
		<td rowspan="4">Kategori Sasaran</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueReference</td>
	</tr>
	<tr>
		<td rowspan="3">Observation</td>
		<td>Observation.code.coding</td>
	</tr>
	<tr>
		<td>Observation.category.coding</td>
	</tr>
	<tr>
		<td>Observation.valueCodeableConcept.coding</td>
	</tr>
	<tr>
		<td>4</td>
		<td colspan="5">Skrining</td>
	</tr>
	<tr>
		<td rowspan="3"><td/>
		<td rowspan="3">a</td>
		<td rowspan="3">Hasil Skrining</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item</td>
	<tr>
		<td rowspan="2">Immunization</td>
		<td>Immunization.status</td>
	</tr>
	<tr>
		<td>Immunization.statusReason.coding</td>
	</tr>
	<tr>
		<td>5</td>
		<td colspan="4">Hasil Pelayanan Imunisasi</td>
	</tr>
	<tr>
		<td rowspan="33"><td/>
		<td rowspan="3">a</td>
		<td rowspan="3">Jenis Vaksin COVID-19 (Merek)</td>
		<td rowspan="3">Immunization</td>
		<td>Immunization.vaccineCode.coding.system</td>
	</tr>
	<tr>
		<td>Immunization.vaccineCode.coding.code</td>
	</tr>
	<tr>
		<td>Immunization.vaccineCode.coding.display</td>
	</tr>
	<tr>
		<td>b</td>
		<td>Nomor Batch</td>
		<td>Immunization</td>
		<td>Immunization.lotNumber</td>
	</tr>
	<tr>
		<td>c</td>
		<td>Tanggal Imunisasi</td>
		<td>Immunization</td>
		<td>Immunization.occurrenceDateTime</td>
	</tr>
	<tr>
		<td>d</td>
		<td>Jam Imunisasi</td>
		<td>Immunization</td>
		<td>Immunization.occurrenceDateTime</td>
	</tr>
	<tr>
		<td>e</td>
		<td>Tanggal Pencatatan</td>
		<td>Immunization</td>
		<td>Immunization.recorded</td>
	</tr>
	<tr>
		<td>f</td>
		<td>Urutan Nomor Dosis Pemberian</td>
		<td>Immunization</td>
		<td>Immunization.protocolApplied.doseNumberPositiveInt</td>
	</tr>
	<tr>
		<td rowspan="4">g</td>
		<td rowspan="4">Dosis Imunisasi</td>
		<td rowspan="4">Immunization</td>
		<td>Immunization.doseQuantity[0].value[0]</td>
	</tr>
	<tr>
		<td>Immunization.doseQuantity[0].unit[0]</td>
	</tr>
	<tr>
		<td>Immunization.doseQuantity[0].system[0]</td>
	</tr>
	<tr>
		<td>Immunization.doseQuantity[0].code[0]</td>
	</tr>
	<tr>
		<td rowspan="3">h</td>
		<td rowspan="3">Kategori Imunisasi</td>
		<td rowspan="3">Immunization</td>
		<td>Immunization.reasonCode.coding.system</td>
	</tr>
	<tr>
		<td>Immunization.reasonCode.coding.code</td>
	</tr>
	<tr>
		<td>Immunization.reasonCode.coding.display</td>
	</tr>
	<tr>
		<td>i</td>
		<td>Sumber Data Imunisasi</td>
		<td>Immunization</td>
		<td>Immunization.primarySource</td>
	</tr>
	<tr>
		<td>j</td>
		<td>Pasien</td>
		<td>Immunization</td>
		<td>Immunization.patient</td>
	</tr>
	<tr>
		<td>k</td>
		<td>Kunjungan Imunisasi</td>
		<td>Immunization</td>
		<td>Immunization.encounter</td>
	</tr>
	<tr>
		<td rowspan="8">l</td>
		<td colspan="3">Tenaga Kesehatan atau Organisasi yang Terlibat dalam Proses Imunisasi</td>
	</tr>
	<tr>
		<td rowspan="3">1) Peran Tenaga Kesehatan dalam Proses Imunisasi</td>
		<td rowspan="3">Immunization</td>
		<td>Immunization.performer.function.system</td>
	</tr>
	<tr>
		<td>Immunization.performer.function.code</td>
	</tr>
	<tr>
		<td>Immunization.performer.function.display</td>
	</tr>
	<tr>
		<td rowspan="2">2) Tenaga Kesehatan yang Terlibat dalam Proses Imunisasi</td>
		<td rowspan="2">Immunization</td>
		<td>Immunization.performer.actor.reference</td>
	</tr>
	<tr>
		<td>Immunization.performer.actor.display</td>
	</tr>
	<tr>
		<td rowspan="2">3) Organisasi Induk yang Terlibat dalam Proses Imunisasi</td>
		<td rowspan="2">Immunization</td>
		<td>Immunization.performer.actor.reference</td>
	</tr>
	<tr>
		<td>Immunization.performer.actor.display</td>
	</tr>
	<tr>
		<td rowspan="3">m</td>
		<td rowspan="3">Rute Pemberian Imunisasi</td>
		<td rowspan="3">Immunization</td>
		<td>Immunization.route.coding.system</td>
	</tr>
	<tr>
		<td>Immunization.route.coding.code</td>
	</tr>
	<tr>
		<td>Immunization.route.coding.display</td>
	</tr>
	<tr>
		<td rowspan="4">n</td>
		<td rowspan="4">Reaksi KIPI</td>
		<td rowspan="4">Immunization</td>
		<td>Immunization.reaction.date</td>
	</tr>
	<tr>
		<td>Immunization.reaction.detail.reference</td>
	</tr>
	<tr>
		<td>Immunization.reaction.detail.display</td>
	</tr>
	<tr>
		<td>Immunization.reaction.reported</td>
	</tr>
	<tr>
		<td>6</td>
		<td>Hasil Observasi</td>
		<td>QuestionnaireResponse</td>
		<td>QuestionnaireResponse.item.item.answer.valueCoding</td>
	</tr>
	<tr>
		<td>7</td>
		<td colspan="4">Gejala Kejadian Ikutan Pasca Imunisasi (KIPI)</td>
	</tr>
	<tr>
		<td rowspan="3"></td>
		<td rowspan="3">a</td>
		<td rowspan="3">Gejala KIPI</td>
		<td rowspan="3">Observation</td>
		<td>Observation.code.coding</td>
	</tr>
	<tr>
		<td>Observation.category.coding</td>
	</tr>
	<tr>
		<td>Observation.valueCodeableConcept.coding</td>
	</tr>
	<tr>
		<td>8</td>
		<td colspan="4">Diagnosis</td>
	</tr>
	<tr>
		<td rowspan="9"></td>
		<td rowspan="9">a</td>
		<td colspan="3">Diagnosis Akhir / Keluar</td>
	</tr>
	<tr>
		<td rowspan="4">1. Diagnosis Primer / Utama</td>
		<td rowspan="3">Encounter</td>
		<td>Encounter.diagnosis.condition</td>
	</tr>
	<tr>
		<td>Encounter.diagnosis.use</td>
	</tr>
	<tr>
		<td>Encounter.diagnosis.rank</td>
	</tr>
	<tr>
		<td>Condition</td>
		<td>Condition.code</td>
	</tr>
	<tr>
		<td rowspan="4">2. Diagnosis Sekunder / Penyerta</td>
		<td rowspan="3">Encounter</td>
		<td>Encounter.diagnosis.condition.code</td>
	</tr>
	<tr>
		<td>Encounter.diagnosis.use</td>
	</tr>
	<tr>
		<td>Encounter.diagnosis.rank</td>
	</tr>
	<tr>
		<td>Condition</td>
		<td>Condition.code</td>
	</tr>
	<tr>
		<td rowspan="3">9</td>
		<td rowspan="3">Tindakan / Prosedur Medis </td>
		<td rowspan="3">Procedure</td>
		<td>Procedure.code.coding</td>
	</tr>
	<tr>
		<td>Procedure.category.coding</td>
	</tr>
	<tr>
		<td>Procedure.reasonCode.coding
	</tr>
</table>

### <div id="SearchPatientPractitionerOrganization" style="font-weight: bold;">Pre-Use Case Requirement</div>

<div style="margin-left: 30px;">
<h4 style="font-weight: bold;">Registrasi Struktur Organisasi</h4>

{{render:organization-structure-schema.png}}

<center><i>Gambar 2. Contoh Struktur Organisasi</i></center><br>

<p>Organisasi merupakan data terkait struktur organisasi yang ada di dalam suatu institusi. Data struktur organisasi ini akan dijadikan referensi saat data pelayanan kesehatan dikirimkan ke SATUSEHAT. Institusi yang akan melakukan integrasi ke SATUSEHAT perlu melakukan registrasi atau mengirimkan data terkait struktur organisasi yang tersedia di dalam institusi tersebut (selanjutnya disebut suborganisasi). Institusi yang termasuk dalam kategori fasilitas pelayanan kesehatan (selanjutnya disebut organisasi induk), akan mendapatkan ID dari Kementerian Kesehatan setelah melakukan registrasi. Organisasi induk selanjutnya akan mengirimkan struktur organisasi/suborganisasi yang ada dalam institusi tersebut. Contoh struktur organisasi dapat dilihat dalam Gambar 1. Setiap suborganisasi di bawah organisasi induk perlu dikirimkan datanya ke SATUSEHAT.</p>

<p>Data suborganisasi dikirimkan menggunakan resource Organization dengan metode POST. Resource Organization digunakan untuk mencatat data sekelompok orang atau organisasi dengan tujuan yang sama. Hal ini ditunjukkan dengan adanya struktur pengurus dari organisasi tersebut. Template pengisian organisasi dapat diakses pada tautan berikut : <a href="https://docs.google.com/spreadsheets/d/1JBP2aUtPqCrsIyVvr2Mus1DMeLTumBn9a0azIHyv4f4/edit#gid=1571590515">Template Registrasi Organization & Location</a></p>

<p>Pemetaan nilai terkait Pengiriman Data Registrasi Struktur Organisasi dapat merujuk ke modul pelayanan yang terkait, baik <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/">Modul Rawat Jalan, IGD, maupun Rawat Inap di SATUSEHAT.</a></p>

<h4 style="font-weight: bold;">Registrasi Struktur Lokasi</h4>

{{render:location-structure-schema.png}}

<center><i>Gambar 3. Contoh Struktur Lokasi</i></center><br>

<p>Struktur lokasi merupakan lokasi fisik yang dapat berupa bangunan, ruangan yang menjadi tempat dimana layanan kesehatan dilakukan. Institusi yang akan melakukan integrasi ke SATUSEHAT perlu melakukan registrasi atau mengirimkan data terkait struktur lokasi yang tersedia di dalam institusi tersebut. Data struktur lokasi yang dimaksud adalah detail dan informasi posisi untuk tempat fisik di mana layanan disediakan dan sumber daya dan peserta dapat disimpan, ditemukan, ditampung, atau diakomodasi. Contoh struktur lokasi dapat dilihat dalam Gambar 2. Setiap lokasi dari struktur tersebut perlu dikirimkan datanya ke SATUSEHAT untuk keperluan informasi dimana suatu layanan dilakukan.</p>

<p>Data struktur dikirimkan menggunakan resource Location dengan metode POST. Template pengisian struktur lokasi dapat diakses pada link berikut: <a href="https://docs.google.com/spreadsheets/d/1JBP2aUtPqCrsIyVvr2Mus1DMeLTumBn9a0azIHyv4f4/edit#gid=1571590515">Template Registrasi Organization & Location</a></p>

<p>Pemetaan nilai terkait Pengiriman Data Registrasi Struktur Lokasi dapat merujuk ke modul pelayanan yang terkait, baik <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/">Modul Rawat Jalan, IGD, maupun Rawat Inap di SATUSEHAT.</a></p>

<h4 style="font-weight: bold;">Nomor IHS untuk Tenaga Kesehatan</h4>
<p>Apabila melakukan pengiriman data kesehatan melalui SATUSEHAT yang memiliki elemen data terkait tenaga kesehatan, maka diperlukan informasi {practitioner-ihs-number} dari tenaga kesehatan yang bersangkutan. {practitioner-ihs-number} seorang tenaga kesehatan didapatkan dari Master Nakes Index (MNI) Kementerian Kesehatan. MNI menyimpan data-data Nakes dari seluruh sumber yang secara resmi menerbitkan daftar tenaga kesehatan. Setelah mendapatkan {practitioner-ihs-number}, ID tersebut dapat disimpan di masing-masing sistem internal fasilitas kesehatan.</p>

<p>Proses pencarian Nomor IHS dari tenaga kesehatan dapat dilakukan melalui FHIR API dengan metode GET. Untuk metode pencarian data nakes di SATUSEHAT secara detail dapat dilihat dalam link <a href="https://satusehat.kemkes.go.id/platform/docs/id/api-catalogue/onboardings/apis/practitioner/">berikut</a>. </p>

Proses pencarian data fasyankes dan nakes dapat dilakukan melalui FHIR API dengan metode GET dengan parameter dibawah ini:

| No  | Data        | Resource      | Parameter Pencarian             |
| --- |------------ | ------------- | --------------------------------|
| 1   | Fasyankes   | Organization  | &lcub;organization-ihs-number&rcub;      |
| 2   | Lokasi      | Location      | &lcub;&lcub;id-resource-Location&rcub;&rcub;        |
| 3   | Nakes       | Practitioner  | NIK, &lcub;practitioner-ihs-number&rcub;    |

</div>

### <div id="step1" style="font-weight: bold;">1. Pendaftaran Pasien</div>
<div style="margin-left: 30px;">
<p>Apabila melakukan pengiriman data kesehatan melalui SATUSEHAT yang memiliki elemen data terkait pasien, maka diperlukan informasi {patient-ihs-number} dari pasien yang bersangkutan. {patient-ihs-number} seorang pasien didapatkan dari Master Patient Index (MPI) Kementerian Kesehatan. MPI menyimpan data-data demografi pasien berskala nasional, mulai dari nama, tanggal lahir, alamat, Identitas resmi yang diterbitkan pemerintah, dan lain lain. Setelah mendapatkan {patient-ihs-number}, ID dapat disimpan secara di masing-masing sistem internal fasyankes maupun partner non-fasyankes. {patient-ihs-number} akan mempermudah pelaporan pelayanan kesehatan yang berhubungan dengan pasien, karena partner tidak diwajibkan menyertakan data diri setiap ada pengiriman data {patient-ihs-number} juga dapat digunakan untuk melihat data diri pasien secara menyeluruh.</p>

<p>Proses pencarian {patient-ihs-number} dari pasien dapat dilakukan melalui FHIR API dengan metode GET. Untuk metode pencarian data pasien di SATUSEHAT secara detail dapat dilihat dalam dokumen <a href="https://docs.google.com/document/d/1wGsuxUJcmWsGhTdAthe0pmcnsqtggLlQdFUG5fU4_T4/edit#heading=h.4fzggw2guay3">Petunjuk Teknis SATUSEHAT (Juknis SATSET)</a>.</p>
</div>

### <div id="step2" style="font-weight: bold;">2. Pendaftaran Kunjungan Pasien</div>
<div style="margin-left: 30px;">
<p>Kunjungan pasien dapat didefinisikan sebagai interaksi pasien terhadap suatu layanan fasyankes. Sebagai contoh, dalam satu rangkaian rawat jalan, seluruh rangkaian dapat didefinisikan sebagai satu “Encounter”. Data-data kunjungan pasien yang direkam meliputi kapan pertemuan tersebut mulai dan selesai, siapa tenaga kesehatan yang melayani, siapa subjek dari pelayanannya, dan informasi pendukung lainnya.</p>

<p>Pemetaan nilai serta pemetaan variabel dan terminologi spesifik terkait Pendaftaran Kunjungan Pasien dapat merujuk ke modul pelayanan yang terkait, baik <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/">Modul Rawat Jalan, IGD, maupun Rawat Inap di SATUSEHAT</a>.</p>

<!--Part 1-1 Variable Pendataan Kunjungan-->
<details>
	<summary>
		<h4>&#10133; Pembuatan Kunjungan Baru</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-1-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-1-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-1-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-1-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-1-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Encounter-Create-PendataanKunjungan}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "arrived",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "AMB",
        "display": "ambulatory"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-1-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
<!--END Part 1-1-->

<!--Part 1-2-->
<details>
	<summary>
		<h4>&#10133; Masuk ke ruang pemeriksaan</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-1-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-1-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-1-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-1-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-1-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">{{json:covid/vaksin/Encounter-Create-InProgress.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "in-progress",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "AMB",
        "display": "ambulatory"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        },
        {
            "status": "in-progress",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ENCOUNTER_PERIOD1_END__  | Waktu mulai/check-out kunjungan |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"

</div>
</div>

<div role="tabpanel" class="tab-pane" id="valueset-1-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
<!--END Part 1-2-->
</div>
<!--END Part 1-->

<!--Part 3-->
### <div id="step3" style="font-weight: bold;">3. Penentuan Sasaran</div>

<div style="margin-left: 30px;">
<!--Part 3-1 Variable Kategori Sasaran-->
<details>
	<summary>
<h4>&#10133; Kategori Sasaran</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-3-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-3-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-3-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-3-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-3-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KategoriSasaran}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "survey",
                    "display": "Survey"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://terminology.kemkes.go.id/CodeSystem/clinical-term",
                "code": "OC000133",
                "display": "Kategori Sasaran Imunisasi COVID-19"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi, referensi ke value set "Kategori Sasaran" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Kategori Sasaran</div>

<!--| No | Kode (Observation.code.coding[x].code)       | Display  (Observation.code.coding[x].display) | System  (Observation.code.coding[x].system)|-->
| No | System | Kode | Display | Keterangan  |
|-|-|-|-|-|
| 1 | http://snomed.info/sct | 105436006 | Elderly person | Lanjut Usia  |
| 2 | http://snomed.info/sct | 223366009 | Healthcare professional | Tenaga kesehatan yang bertugas di garda terdepan  |
| 3 | http://snomed.info/sct | 255409004 | Pregnant woman | Ibu Hamil  |
| 4 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000285 | Penyandang immunocompromised sedang-berat (orang yang mengalami gangguan sistem imun) | Penyandang immunocompromised sedang-berat (orang yang mengalami gangguan sistem imun)  |
| 5 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000286 | Dewasa dengan komorbid | Dewasa dengan komorbid  |
| 6 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000293 | Lanjut Usia > 60 dengan komorbid |  Lanjut Usia > 60 dengan komorbid  |


</div>
</div>
<br>
</details>
<!--END Part 3-1-->
</div>



### <div id="step4" style="font-weight: bold;">4. Skrining</div>

<div style="margin-left: 30px;">
<!--Part 4-1 Variable Suhu-->
<details>
	<summary>
<h4>&#10133; Suhu</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-4-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-4-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-4-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-4-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-4-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-Suhu}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
					"code": "vital-signs",
					"display": "Vital Signs"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://loinc.org",
				"code": "8310-5",
				"display": "Body temperature"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
	"performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
	"valueQuantity": {
		"value": <strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>,
		"unit": "C",
		"system": "http://unitsofmeasure.org",
		"code": "Cel"
	}
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		| Nilai observasi untuk suhu tubuh pasien dalam satuan Celcius |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-4-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
[none]
</div>
</div>
<br>
</details>
<!--END Part 4-1-->


<!--Part 4-2 Variable Tekanan Darah Sistolik-->
<details>
	<summary>
<h4>&#10133; Tekanan Darah Sistolik</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-4-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-4-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-4-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-4-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-4-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-Sistolik}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
					"code": "vital-signs",
					"display": "Vital Signs"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://loinc.org",
				"code": "8480-6",
				"display": "Systolic blood pressure"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
	"performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
	"valueQuantity": {
		"value": <strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>,
		"unit": "mm[Hg]",
		"system": "http://unitsofmeasure.org",
		"code": "mm[Hg]"
	}
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		|  Nilai observasi untuk tekanan darah sistolik pasien dalam satuan mmHg |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-4-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
[none]
</div>
</div>
<br>
</details>
<!--END Part 4-2-->


<!--Part 4-3 Variable Tekanan Darah Diastolik-->
<details>
	<summary>
<h4>&#10133; Tekanan Darah Diastolik</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-4-3" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-4-3" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-4-3" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-4-3" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-4-3">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-Diastolik}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-4-3" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
					"code": "vital-signs",
					"display": "Vital Signs"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://loinc.org",
				"code": "8462-4",
				"display": "Diastolic blood pressure"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
	"performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
	"valueQuantity": {
		"value": <strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>,
		"unit": "mm[Hg]",
		"system": "http://unitsofmeasure.org",
		"code": "mm[Hg]"
	}
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-4-3" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		|  Nilai observasi untuk tekanan darah diastolik pasien dalam satuan mmHg |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-4-3" style="border: 1px solid #e8edee; padding: 15px 10px;">
[none]
</div>
</div>
<br>
</details>
<!--END Part 4-3-->
</div>

### <div id="step5" style="font-weight: bold;">5. Hasil Pelayanan Imunisasi</div>

<div style="margin-left: 30px;">
<p>Pengiriman data tindakan imunisasi dan riwayat imunisasi dilakukan melalui resource Immunization.</p>

<p>Pemetaan nilai resource Immunization, tipe mandatoris, deskripsi, dan format pengisian dari setiap elemen data/path dapat merujuk ke <a href="https://satusehat.kemkes.go.id/platform/docs/id/interoperability/imunisasi-new/">Modul Imunisasi</a>. Untuk contoh pengiriman data atau payload dari Immunization dapat dilihat dalam <a href="http://s.id/PostmanSATUSEHAT">Postman Collection</a>.</p>

<!--Part 5-1-->
<details>
	<summary>
<h4>&#10133; a. Imunisasi dilakukan oleh Nakes</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Complete-ByNakes-1.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "expirationDate": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_EXPIRATIONDATE&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "IM-Khusus",
                    "display": "Imunisasi Program Khusus"
                }
            ]
        }
    ],
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_EXPIRATIONDATE__     | Tanggal kadaluarsa vaksin yang diberikan dengan tipe data date dalam format YYYY-MM-DD |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--END Part 5-1-->

<!--Part 5-2-->
<details>
<summary>
<h4>&#10133; b. Imunisasi ditunda</h4>
</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Tunda.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "not-done",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-2" style="border: 1px solid #e8edee; padding: 15px 10px;">


| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi, sehingga kolom ini hanya diisi apabila Immunization.status= "not-done". Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--END Part 5-2-->


<!--Part 5-3-->
<details>
	<summary>
<h4>&#10133; c. Imunisasi tidak diberikan</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-3" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-3" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-3" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-3" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-3">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-TidakVaksin.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-3" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "not-done",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
	"statusReason": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_STATUS_REASON&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "primarySource": true,
    "location": {
        "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-3" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __VACCINE_STATUS_REASON__    | __(*)__ Berisi data alasan yang menyebabkan tidak dilakukannya vaksinasi, sehingga kolom ini hanya diisi apabila Immunization.status= "not-done". Referensi ke value set "Alasan Tidak Dilakukan Imunisasi"|
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-3" style="border: 1px solid #e8edee; padding: 15px 10px;">

<!--|x | Immunization.vaccineCode.coding[x].code | Immunization.vaccineCode.coding[x].display | Immunization.vaccineCode.coding[x].system | Immunization.vaccineCode.coding[x].code | Immunization.vaccineCode.coding[x].display | Immunization.vaccineCode.coding[x].system | Immunization.vaccineCode.coding[x].code | Immunization.vaccineCode.coding[x].display | Immunization.vaccineCode.coding[x].system |-->

##### Jenis Vaksin COVID-19
| No. | KFA Code - PV | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
<br>
</details>
<!--END Part 5-3-->


<!--Part 5-4-->
<details>
	<summary>
<h4>&#10133; d. Imunisasi dilakukan oleh Nakes dilaporkan KIPI oleh Nakes</h4>
    </summary>

<h5>Imunisasi</h5>
<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-4" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-4" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-4" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-4" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-4">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Immunization-Create-Imunisasi-Complete-ByNakes-2.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-4" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "reaction":  [
        {
            "date": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REACTION_DATE&rcub;&rcub;</strong>",
            "detail": {
                "reference": "Observation/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_OBSERVATION&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REACTION_DISPLAY&rcub;&rcub;</strong>"
            },
            "reported": false
        }
    ],
    "primarySource": true,
    "location": {
        "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_LOCATION_NAME&rcub;&rcub;</strong>"
    },
    "lotNumber": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_BATCH_NO&rcub;&rcub;</strong>",
    "route": {
        "coding":  [
            {
                "system": "http://www.whocc.no/atc",
                "code": "inj.intramuscular",
                "display": "Injection Intramuscular"
            }
        ]
    },
    "doseQuantity": {
        "value": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_QTY&rcub;&rcub;</strong>",
        "unit": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>",
        "system": "http://unitsofmeasure.org",
        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_UNIT&rcub;&rcub;</strong>"
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        },
        {
            "function": {
                "coding":  [
                    {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_ROLE&rcub;&rcub;</strong>"
                    }
                ]
            },
            "actor": {
                "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "IM-Khusus",
                    "display": "Imunisasi Program Khusus"
                }
            ]
        }
    ],
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-4" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_REACTION_DATE__      		| data waktu ketika reaksi vaksin terjadi 
| __ID_RESOURCE_OBSERVATION__      		| Data informasi detail mengenai reaksi vaksin dengan tipe data Reference yang direferensikan ke data yang tersimpan di resource Observation |
| __IMMUNIZATION_REACTION_DISPLAY__ | Deskripsi data reaksi yang terjadi setelah pemberian vaksin/imunisasi atau Kejadian Ikutan Pasca Imunisasi (KIPI) |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __IMMUNIZATION_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |
| __IMMUNIZATION_BATCH_NO__| Nomor batch vaksin yang diberikan dengan tipe data string |
| __IMMUNIZATION_DOSE_QTY__| Jumlah dosis vaksinasi yang diberikan dalam 1 pemberian dengan tipe data SimpleQuantity. |
| __IMMUNIZATION_DOSE_UNIT__| Satuan dosis vaksinasi yang diberikan dalam 1 pemberian |
| __IMMUNIZATION_PERFORMER_ROLE__| __(*)__ Berisi data peran tenaga kesehatan dalam proses vaksin/imunisasi. Referensi ke value set "Peran Tenaga Kesehatan dalam Proses Imunisasi" |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-4" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

##### Jenis Vaksin COVID-19
| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
</div>
<br>
<!--END Part 5-4-->


<!--Part 5-5-->
<h5>KIPI terpantau Nakes</h5>
<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-5" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-5" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-5" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-5" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-5">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KIPI-Malaise}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-5" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "exam",
                    "display": "Exam"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://loinc.org",
                "code": "31047-1",
                "display": "Immunization reaction"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-5" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi. Referensi ke value set "Gejala KIPI" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-5" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

##### Gejala KIPI

| No. | Kode | Display | System | Keterangan  |
|-|-|-|-|-|
| 1 | 49727002 | Cough | http://snomed.info/sct | Batuk  |
| 2 | 82272006 | Common cold | http://snomed.info/sct | Pilek  |
| 3 | 422587007 | Nausea | http://snomed.info/sct | Mual  |
| 4 | 422400008 | Vomiting | http://snomed.info/sct | Muntah  |
| 5 | 44169009 | Loss of sense of smell | http://snomed.info/sct | Hilang penciuman  |
| 6 | 3695500 | Loss of taste | http://snomed.info/sct | Hilang pengecapan  |
| 7 | 128540005 | Hearing disorder | http://snomed.info/sct | Gangguan pendengaran  |
| 8 | 95677002 | Disorder of vision | http://snomed.info/sct | Gangguan penglihatan  |
| 9 | 404640003 | Dizziness | http://snomed.info/sct | Pusing  |
| 10 | 25064002 | Headache | http://snomed.info/sct | Sakit kepala  |
| 11 | 81308009 | Disorder of brain | http://snomed.info/sct | Ensefalopati, kelainan otak  |
| 12 | 443371007 | Decreased level of consciousness | http://snomed.info/sct | Penurunan kesadaran  |
| 13 | 271594007 | Syncope | http://snomed.info/sct | Pingsan  |
| 14 | OV000160 | Demam <39°C | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Demam <39°C  |
| 15 | OV000161 | Demam ≥39°C | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Demam ≥39°C  |
| 16 | 13791008 | Asthenia | http://snomed.info/sct | Lemas/ letih/ lesu  |
| 17 | 271782001 | Drowsy | http://snomed.info/sct | Mengantuk  |
| 18 | 367391008 | Malaise | http://snomed.info/sct | Malaise  |
| 19 | OV000171 | Rewel | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Rewel  |
| 20 | OV000166 | Persistent inconsolable screaming | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Jeritan terus-menerus yang tidak dapat dihibur  |
| 21 | 48694002 | Anxiety | http://snomed.info/sct | Reaksi kecemasan  |
| 22 | 267036007 | Dyspnea | http://snomed.info/sct | Sesak napas  |
| 23 | 271681002 | Stomach ache | http://snomed.info/sct | Sakit perut  |
| 24 | 62315008 | Diarrhea | http://snomed.info/sct | Diare  |
| 25 | 18165001 | Jaundice | http://snomed.info/sct | Kuning/ikterus  |
| 26 | 119419001 | Cyanosis of skin | http://snomed.info/sct | Kebiruan pada tubuh  |
| 27 | 248456009 | Shivering or rigors | http://snomed.info/sct | Kedinginan/menggigil  |
| 28 | 91175000 | Seizure | http://snomed.info/sct | Kejang  |
| 29 | 41497008 | Febrile convulsion | http://snomed.info/sct | Kejang demam  |
| 30 | OV000163 | Kemerahan anggota tubuh | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Kemerahan anggota tubuh  |
| 31 | 213338000 | Injection site erythema | http://snomed.info/sct | Kemerahan pada lokasi penyuntikan  |
| 32 | 271807003 | Eruption of skin | http://snomed.info/sct | Ruam pada tubuh  |
| 33 | 418290006 | Itching | http://snomed.info/sct | Gatal pada tubuh  |
| 34 | 846686009 | Injection site itching | http://snomed.info/sct | Gatal pada lokasi penyuntikan  |
| 35 | 95388000 | Injection site pain | http://snomed.info/sct | Nyeri pada lokasi penyuntikan  |
| 36 | 68962001 | Muscle pain | http://snomed.info/sct | Nyeri otot/ mialgia  |
| 37 | 57676002 | Joint pain | http://snomed.info/sct | Nyeri sendi  |
| 38 | 29857009 | Chest pain | http://snomed.info/sct | Nyeri dada  |
| 39 | 16331000 | Heartburn | http://snomed.info/sct | Nyeri ulu hati  |
| 40 | 65124004 | Swelling | http://snomed.info/sct | Pembengkakan  |
| 41 | 297142003 | Foot swelling | http://snomed.info/sct | Pembengkakan pada kaki  |
| 42 | 271587009 | Stiffness | http://snomed.info/sct | Kaku  |
| 43 | 55300003 | Cramp | http://snomed.info/sct | Keram  |
| 44 | 44077006 | Numbness | http://snomed.info/sct | Kebas  |
| 45 | 62507009 | Pins and needles | http://snomed.info/sct | Kesemutan  |
| 46 | 30746006 | Lymphadenopathy | http://snomed.info/sct | Pembengkakan kelenjar getah bening  |
| 47 | 213340005 | Injection site swelling | http://snomed.info/sct | Bengkak pada lokasi penyuntikan  |
| 48 | 713514005 | Muscle weakness of limb | http://snomed.info/sct | Kelemahan anggota gerak  |
| 49 | OV000172 | Perdarahan lain | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Perdarahan lain  |
| 50 | OV000173 | Perdarahan pada lokasi penyuntikan | [http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term) | Perdarahan pada lokasi penyuntikan  |
| 51 | 39579001 | Anaphylaxis | http://snomed.info/sct | Anafilaksis  |
| 52 | 890091002 | Hypotonic-hyporesponsive episode | http://snomed.info/sct | Hypotonic, hyporesponsive episode (HHE)  |
| 53 | 302215000 | Thrombocytopenic disorder | http://snomed.info/sct | Trombositopenia  |
| 54 | 40956001 | Guillain-Barré syndrome | http://snomed.info/sct | Sindrom Guillain Barre  |
| 55 | 72893007 | Brachial neuritis | http://snomed.info/sct | Neuritis brakialis  |
| 56 | 95383009 | Injection site sterile abscess | http://snomed.info/sct | Abses steril pada lokasi penyuntikan  |
| 57 | 186478009 | Acute paralytic poliomyelitis, vaccine-associated | http://snomed.info/sct | Vaccine-associated paralytic poliomyelitis (VAPP)  |
| 58 | 74964007 | Other | http://snomed.info/sct | Lainnya  |

</div>
</div>
</div>
<br>
</details>
<!--END Part 5-5-->

<!--
//Part 5-6
<details>
	<summary>
<h4>&#10133; e. Riwayat Vaksinasi dilaporkan oleh Kader</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-5-6" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-5-6" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-5-6" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-5-6" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

//Tab panes
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-5-6">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Immunization-Create-Imunisasi-Complete-ByKader}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-5-6" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Immunization",
    "status": "completed",
    "vaccineCode": {
        "coding":  [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_TYPE&rcub;&rcub;</strong>"
            }
        ]
    },
    "patient": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "occurrenceDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_OCCURENCEDATETIME&rcub;&rcub;</strong>",
    "recorded": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_RECORDED&rcub;&rcub;</strong>",
    "primarySource": false,
    "reportOrigin": {
        "coding":  [
            {
                "system": "http://terminology.hl7.org/CodeSystem/immunization-origin",
                "code": "provider",
                "display": "Other Provider"
            }
        ]
    },
    "performer":  [
        {
            "function": {
                "coding":  [
                    {
                        "system": "http://terminology.hl7.org/CodeSystem/v2-0443",
                        "code": "EP",
                        "display": "Entering Provider (probably not the same as transcriptionist?)"
                    }
                ],
                "text": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_PERFORMER_NAME&rcub;&rcub;</strong>"
            },
            "actor": {
                "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode":  [
        {
            "coding":  [
                {
                    "system": "http://terminology.kemkes.go.id/CodeSystem/immunization-reason",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_REASON&rcub;&rcub;</strong>"
                }
            ]
        }
    ],
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": "<strong style="color:#00a7ff">&lcub;&lcub;IMMUNIZATION_DOSE_NUMBER&rcub;&rcub;</strong>"
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-5-6" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __VACCINE_TYPE__    | __(*)__ Jenis vaksin. Berisi dua pemilihan cara penginputan data kode vaksin: <br> 1. Pencatatan di mana produk/brand vaksin diketahui (Pencatatan langsung oleh tenaga kesehatan): Terdapat 3 kelompok kode yang perlu dikirimkan yaitu Kode produk vaksin aktual dari kamus farmasi dan alat kesehatan (KFA Code), CVX group, CVX name <br> 2. Pencatatan riwayat imunisasi: dapat mengirimkan kode CVX group. <br>Referensi ke value set "Jenis Vaksin COVID-19"|
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __IMMUNIZATION_OCCURENCEDATETIME__     |  Kapan vaksin diadministrasikan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_RECORDED__     |  Kapan pencatatan vaksin dicatatkan (kemungkinan terjadi setelah vaksin diadministrasikan) dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz |
| __IMMUNIZATION_PERFORMER_NAME__     | Nama kader yang ikut serta dalam proses vaksin/imunisasi |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __IMMUNIZATION_REASON__      | Kategori imunisasi yang dilakukan berdasarkan hierarki yang tertulis di Peraturan Menteri Kesehatan No. 12 tahun 2017 tentang Penyelenggaraan Imunisasi dengan tipe data CodeableConcept. Khusus imunisasi rutin (IM-Rutin), wajib dikirimkan tambahan klasifikasi waktu pemberian imunisasi rutin yaitu Imunisasi Ideal dan Kejar. |
| __IMMUNIZATION_DOSE_NUMBER__| Urutan dosis vaksin dalam seri pemberian vaksin yang direkomendasikan untuk diisi dengan tipe data positiveInt. |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-5-6" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>


##### Jenis Vaksin COVID-19 

| No. | KFA Code (PV) | POA - Produk Obat Aktual | KFA System | CVX Grup Code | CVX Group Display | CVX Group System | CVX Name Code | CVX Name Display | CVX Name System  |
|-|-|-|-|-|-|-|-|-|-|
| 1 | [93003775](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [Vaksin COVID-19, Inactivated 3 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93003775) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 2 | [93004035](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (ASTRAZENECA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004035) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 3 | [93004052](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [Vaksin COVID-19 Rekombinan, 25 ug/0.5 mL (INDOVAC, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004052) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 4 | [93004088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 2)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 5 | [93004423](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 3)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004423) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 6 | [93004892](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [Vaksin COVID-19 mRNA-1273, 100 ug/0.5 mL (SPIKEVAX, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004892) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 207 | COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 7 | [93004956](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (CORONAVAC, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004956) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 8 | [93004965](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [Vaksin COVID-19 Recombinant AD-5 Vector, 100 ug/0.5 mL (CONVIDECIA, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93004965) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 9 | [93015079](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, THAILAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015079) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 10 | [93015081](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015081) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 11 | [93015082](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, AUSTRALIA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015082) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 12 | [93015083](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015083) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 13 | [93015084](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015084) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 14 | [93015085](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, ITALY)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015085) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 15 | [93015086](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 10, USA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015086) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 16 | [93015088](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK, NETHERLAND)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015088) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 17 | [93015090](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (VAXZEVRIA, 8, UK)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015090) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 18 | [93015692](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [Vaksin COVID-19 Recombinant Adenovirus (CHADOX1), 5x10^10 VP/0.5 mL (KCONECAVAC, 10, CHINA)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015692) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 210 | COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 19 | [93015693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (BIOFARMA, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 20 | [93015694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [Vaksin COVID-19, Inactivated 3 ug/0.5 mL (COV2BIO, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93015694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 21 | [93020565](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (Umum)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020565) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 22 | [93020567](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 0,5 mL, 1)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020567) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 23 | [93020570](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 5 mL, 10)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020570) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 24 | [93020573](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [Vaksin COVID-19, Inactivated 6 ug/0,5 mL (COVAXIN, 10 mL, 20)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020573) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 502 | COVID-19 IV Non-US Vaccine (COVAXIN) | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 25 | [93020680](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020680) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 26 | [93020681](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020681) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 27 | [93020682](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020682) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 28 | [93020685](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020685) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 29 | [93020689](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD, 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020689) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 30 | [93020693](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, IDT BIOLOGIKA GMBH (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020693) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 31 | [93020694](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT ANAGNI S.R.L. (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020694) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 32 | [93020695](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, GRAND RIVER ASEPTIC MANUFACTURING (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020695) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 33 | [93020696](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, CATALENT INDIANA LLC(1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020696) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |
| 34 | [93020698](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [Recombinant Novel Adenovirus (ad-26) Vector-Sars-Cov-2 NLT 2.5 X 10^10 VP / 0.5 ml Suspensi Injeksi (JANSSEN COVID-19 VACCINE, ASPEN SVP (PTY) LTD (1), 5)](https://satusehat.kemkes.go.id/kfa-browser/poa-detail/93020698) | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | VG213 | COVID-19 | [http://sys-ids.kemkes.go.id/kfa](http://sys-ids.kemkes.go.id/kfa) | 212 | COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL | [http://hl7.org/fhir/sid/cvx](http://hl7.org/fhir/sid/cvx)  |

##### Alasan Tidak Dilakukan Imunisasi 

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Pasien sudah memiliki imunitas terhadap agen target dari imunisasi | IMMUNE | immunity | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 2 | Pasien memiliki kondisi medis dimana vaksin dikontraindikasikan atau perlu kehati-hatian | MEDPREC | medical precaution | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 3 | Produk kosong | OSTOCK | product out of stock | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 4 | Pasien atau wali pasien menolak | PATOBJ | patient objection | http://terminology.hl 7.org/CodeSystem/v3 -ActReason  |
| 5 | Tunda | IS000001 | Tunda | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |
| 6 | Tidak Vaksin | IS000002 | Tidak Vaksin | [http://terminology.kemkes.go.id/CodeSystem/immunization-statusReason](http://terminology.kemkes.go.id/CodeSystem/immunization-statusReson)  |

##### Pendanaan Vaksin

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | IF000001 | Vaksin Gotong Royong | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |
| 2 | IF000002 | Vaksin Program | [http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource](http://terminology.kemkes.go.id/CodeSystem/immunization-fundingSource)  |

##### Peran Tenaga Kesehatan dalam Proses Imunisasi

| No | Keterangan | Kode | Display | System|
|-|-|-|-|-|
| 1 | Digunakan untuk yang melakukan permintaan |  OP | Ordering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 2 | Digunakan untuk yang melakukan penyuntikan | AP | Administering Provider |  [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |
| 3 | Digunakan untuk yang melaporkan vaksinasi | EP | Entering Provider (probably not the same as transcriptionist?) | [http://terminology.hl7.org/CodeSystem/v2-0443 ](https://hl7.org/fhir/R4/v2/0443/index.html)  |

</div>
</div>
</div>
<br>
</details>
//END Part 5-6
-->

</div>
<!--END Part 2-->

<!--Part 6-->
### <div id="step6" style="font-weight: bold;">6. Form Skrining Imunisasi COVID-19</div>

<div style="margin-left: 30px;">
<p>Form Skrining Imunisasi COVID-19 mencakup data:
<ul>
<li>Verifikasi Identitas</li>
<li>Penentuan Sasaran</li>
<li>Hasil skrining beserta referensinya</li>
<li>Referensi hasil pelayanan imunisasi</li>
<li>Hasil observasi</li>
</ul>
</p>

<!--Part 6-1 Form Skrining Imunisasi COVID-19-->
<details>
	<summary>
<h4>&#10133; Form Skrining Imunisasi COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-6-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-6-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-6-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-6-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-6-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/QuestionnaireResponse-Create-FormSkriningImunisasiCOVID19.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-6-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "QuestionnaireResponse",
    "questionnaire": "https://fhir.kemkes.go.id/Questionnaire/Q0015",
    "status": "completed",
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "authored": "<strong style="color:#00a7ff">&lcub;&lcub;AUTHORED_DATETIME&rcub;&rcub;</strong>",
    "author": {
        "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "source": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "item": [
        {
            "linkId": "1",
            "text": "Verifikasi Data Identitas",
            "item": [
                {
                    "linkId": "1.1",
                    "text": "Dosis terakhir imunisasi COVID-19 yang didapatkan",
                    "answer": [
                        {
                            "valueString": "<strong style="color:#00a7ff">&lcub;&lcub;DOSIS_IMUNISASI_TERAKHIR_FREETEXT&rcub;&rcub;</strong>"
                        }
                    ]
                },
                {
                    "linkId": "1.2",
                    "text": "Kapan terakhir kali menerima imunisasi COVID-19?",
                    "answer": [
                        {
                            "valueDate": "<strong style="color:#00a7ff">&lcub;&lcub;TANGGAL_IMUNISASI_TERAKHIR&rcub;&rcub;</strong>"
                        }
                    ]
                }
            ]
        },
        {
            "linkId": "2",
            "text": "Penentuan Sasaran",
            "item": [
                {
                    "linkId": "2.1",
                    "text": "Usia",
                    "answer": [
                        {
                            "valueCoding": {
                                "system": "<strong style="color:#00a7ff">&lcub;&lcub;KATEGORI_USIA&rcub;&rcub;</strong>",
                                "code": "<strong style="color:#00a7ff">&lcub;&lcub;KATEGORI_USIA&rcub;&rcub;</strong>",
                                "display": "<strong style="color:#00a7ff">&lcub;&lcub;KATEGORI_USIA&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "2.2",
                    "text": "Ibu Hamil",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_IBU_HAMIL&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "2.3",
                    "text": "Tenaga Kesehatan",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_NAKES&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "2.4",
                    "text": "Apakah Anda memiliki penyakit komorbid (jawaban boleh lebih dari satu)",
                    "answer": [
                        {
                            "valueCoding": {
                                "system": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_PENYAKIT_KOMORBID&rcub;&rcub;</strong>",
                                "code": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_PENYAKIT_KOMORBID&rcub;&rcub;</strong>",
                                "display": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_PENYAKIT_KOMORBID&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "2.5",
                    "text": "Apakah Anda memiliki immunocompromised (jawaban boleh lebih dari satu)",
                    "answer": [
                        {
                            "valueCoding": {
                                "system": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_IMMUNOCOMPROMISED&rcub;&rcub;</strong>",
                                "code": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_IMMUNOCOMPROMISED&rcub;&rcub;</strong>",
                                "display": "<strong style="color:#00a7ff">&lcub;&lcub;STATUS_IMMUNOCOMPROMISED&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "2.6",
                    "text": "Kategori Sasaran",
                    "answer": [
                        {
                            "valueReference": {
                                "reference": "Observation/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_OBSERVATION1&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "linkId": "3",
            "text": "Skrining",
            "item": [
                {
                    "linkId": "3.1",
                    "text": "Apakah Anda hari ini dalam keadaan sehat? (komorbid dan imunocompromised Anda dalam kondisi terkontrol)",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_KONDISI_SEHAT&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "3.2",
                    "text": "Suhu",
                    "answer": [
                        {
                            "valueReference": {
                                "reference": "Observation/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_OBSERVATION2&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "3.3",
                    "text": "Tekanan Darah Sistolik",
                    "answer": [
                        {
                            "valueReference": {
                                "reference": "Observation/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_OBSERVATION3&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "3.4",
                    "text": "Tekanan Darah Diastolik",
                    "answer": [
                        {
                            "valueReference": {
                                "reference": "Observation/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_OBSERVATION4&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                },
                {
                    "linkId": "3.5",
                    "text": "Apakah Anda memiliki riwayat alergi berat seperti sesak napas, bengkak dan urtikaria seluruh badan atau reaksi berat lainnya karena vaksin?",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_RIWAYAT ALERGI&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "3.6",
                    "text": "Apakah Anda seorang yang mengidap penyakit autoimun, dan saat ini dalam kondisi aktif?",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_PENYAKIT AUTOIMUN&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "3.7",
                    "text": "Apakah Anda pernah terkonfirmasi menderita COVID-19?",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_RIWAYAT_COVID_19&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "3.8",
                    "text": "Apakah Anda sedang hamil?",
                    "answer": [
                        {
                            "valueBoolean": <strong style="color:#00a7ff">&lcub;&lcub;STATUS_HAMIL&rcub;&rcub;</strong>
                        }
                    ]
                },
                {
                    "linkId": "3.9",
                    "text": "Hasil Skrining",
                    "answer": [
                        {
                            "valueReference": {
                                "reference": "Immunization/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_IMMUNIZATION1&rcub;&rcub;</strong>"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "linkId": "4",
            "text": "Hasil Pelayanan Imunisasi",
            "answer": [
                {
                    "valueReference": {
						"reference": "Immunization/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_IMMUNIZATION2&rcub;&rcub;</strong>"
					}
                }
            ]
        },
        {
            "linkId": "5",
            "text": "Hasil Observasi",
            "answer": [
                {
                    "valueCoding": {
                        "system": "<strong style="color:#00a7ff">&lcub;&lcub;HASIL_OBSERVASI&rcub;&rcub;</strong>",
                        "code": "<strong style="color:#00a7ff">&lcub;&lcub;HASIL_OBSERVASI&rcub;&rcub;</strong>",
                        "display": "<strong style="color:#00a7ff">&lcub;&lcub;HASIL_OBSERVASI&rcub;&rcub;</strong>"
                    },
                    "item": [
                        {
                            "linkId": "5.1",
                            "text": "Sebutkan keluhan jika ada",
                            "answer": [
                                {
                                    "valueString": "<strong style="color:#00a7ff">&lcub;&lcub;KELUHAN&rcub;&rcub;</strong>"
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-6-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__      			| Nama pasien |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __AUTHORED_DATETIME__ 				| Waktu di mana jawaban kuesioner didapatkan dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __DOSIS_IMUNISASI_TERAKHIR__    		| Dosis terakhir imunisasi COVID-19 dengan tipe data free text  |
| __TANGGAL_IMUNISASI_TERAKHIR__    		|  Tanggal terakhir kali menerima imunisasi COVID-19  dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DD |
| __KATEGORI_USIA__    		|  __(*)__ Data kategori usia untuk sasaran imunisasi COVID-19. Referensi ke value set "Penentuan Sasaran - Usia" |
| __STATUS_IBU_HAMIL__    		|  Status apakah sedang hamil dengan tipe data boolean |
| __STATUS_NAKES__    		| Status apakah pekerjaan pasien adalah sebagai tenaga kesehatan dengan tipe data boolean  |
| __STATUS_PENYAKIT_KOMORBID__    		| __(*)__ Status apakah memiliki penyakit komorbid. Referensi ke value set "Penentuan Sasaran - Penyakit Komorbid" |
| __STATUS_IMMUNOCOMPROMISED__    		| __(*)__ Status apakah memiliki immunocompromised. Referensi ke value set "Penentuan Sasaran - Penyakit Immunocompromised" |
| __ID_RESOURCE_OBSERVATION1__    		| &lcub;id-resource-Observation&rcub; pada SATUSEHAT untuk data kategori sasaran penerima vaksin  |
| __ID_RESOURCE_OBSERVATION2__    		| &lcub;id-resource-Observation&rcub; pada SATUSEHAT untuk data suhu tubuh pasien
| __ID_RESOURCE_OBSERVATION3__    		| &lcub;id-resource-Observation&rcub; pada SATUSEHAT untuk data tekanan darah sistolik pasien|
| __ID_RESOURCE_OBSERVATION4__    		| &lcub;id-resource-Observation&rcub; pada SATUSEHAT untuk data tekanan darah diastolik pasien  |
| __STATUS_KONDISI_SEHAT__    		| Status apakah kondisi pasien sehat dengan tipe data boolean   |
| __STATUS_RIWAYAT_ALERGI__    		|   Status riwayat alergi pasien dengan tipe data boolean   |
| __STATUS_PENYAKIT_AUTOIMUN__    		|  Status penyakit autoimun pasien (aktif pada saat ini) dengan tipe data boolean   |
| __STATUS_RIWAYAT_COVID_19__    		|    Status riwayat covid 19 pasien dengan tipe data boolean   |
| __STATUS_HAMIL__    		|   Status hamil pasien dengan tipe data boolean   |
| __ID_RESOURCE_IMMUNIZATION1__    		|  &lcub;id-resource-Immunization&rcub; pada SATUSEHAT untuk data hasil skrining |
| __ID_RESOURCE_IMMUNIZATION2__    		|  &lcub;id-resource-Immunization&rcub; pada SATUSEHAT untuk data hasil pelayanan imunisasi |
| __HASIL_OBSERVASI__    		|  __(*)__ Data hasil observasi pada imunisasi COVID-19. Referensi ke value set "Hasil Observasi" |
| __KELUHAN__    		|  Data keluhan yang dirasakan pasien dalam format free text |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-6-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Kategori</div>

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | 223366009 | Healthcare professional | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |

<div>Penentuan Sasaran - Usia</div>

| No | System | Kode | Display | Keterangan  |
|-|-|-|-|-|
| 1 | http://snomed.info/sct | 105436006 | Elderly person | Lanjut Usia  |
| 2 | http://snomed.info/sct | 223366009 | Healthcare professional | Tenaga kesehatan yang bertugas di garda terdepan  |
| 3 | http://snomed.info/sct | 255409004 | Pregnant woman | Ibu Hamil  |
| 4 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000285 | Penyandang immunocompromised sedang-berat (orang yang mengalami gangguan sistem imun) | Penyandang immunocompromised sedang-berat (orang yang mengalami gangguan sistem imun)  |
| 5 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000286 | Dewasa dengan komorbid | Dewasa dengan komorbid  |
| 6 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | OV000293 | Lanjut Usia > 60 dengan komorbid |  Lanjut Usia > 60 dengan komorbid  |

<div>Penentuan Sasaran - Penyakit Komorbid</div>
| No | System | Kode | Display | Keterangan  |
|-|-|-|-|-|
| 1 | http://snomed.info/sct | 73211009 | Diabetes mellitus | Diabetes Mellitus  |
| 2 | http://snomed.info/sct | 17097001 | Chronic disease of respiratory system | Penyakit Kronis Paru  |
| 3 | http://snomed.info/sct | 128238001 | Chronic heart disease | Penyakit Kronis Jantung  |
| 4 | http://snomed.info/sct | 328383001 | Chronic liver disease | Penyakit Kronis Hati  |
| 5 | http://snomed.info/sct | 709044004 | Chronic kidney disease | Penyakit Kronis Ginjal  |
| 6 | http://snomed.info/sct | 83911000119104,00 | Severe obesity | Obesitas Berat (BMI > 40)  |
| 7 | http://snomed.info/sct | 2667000 | Absent | Tidak  |

<div>Penentuan Sasaran - Penyakit Immunocompromised</div>
| No | System | Kode | Display | Keterangan  |
|-|-|-|-|-|
| 1 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | QRII000002 | Kanker aktif (pengobatan imunosupresif aktif untuk tumor atau keganasan hematologi (termasuk leukemia, limfoma, dan mieloma), atau dalam waktu 12 bulan setelah mengakhiri pengobatan) | Kanker aktif (pengobatan imunosupresif aktif untuk tumor atau keganasan hematologi (termasuk leukemia, limfoma, dan mieloma), atau dalam waktu 12 bulan setelah mengakhiri pengobatan)  |
| 2 | http://snomed.info/sct | 737294004 | Transplant present | Pasien transplantasi  |
| 3 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | QRII000003 | Pasien yang mengalami imunodefisiensi dan secara aktif mendapatkan obat imunosupresan | Pasien yang mengalami imunodefisiensi dan secara aktif mendapatkan obat imunosupresan  |
| 4 | http://terminology.kemkes.go.id/CodeSystem/clinical-term | QRII000004 | ODHA dengan CD4 < 200 sel/μl dengan salah satu/lebih kondisi berikut: infeksi oportunistik, tidak sedang menjalani pengobatan HIV, atau viral load yang terdeteksi | ODHA dengan CD4 < 200 sel/μl dengan salah satu/lebih kondisi sebagai berikut: <br>- infeksi oportunistik <br>- tidak sedang menjalani pengobatan HIV <br>- viral load yang terdeteksi |

<div>Hasil Observasi</div>
| No | System | Kode | Display | Keterangan  |
|-|-|-|-|-|
| 1 | http://snomed.info/sct | 248264000 | No complaints | Tanpa Keluhan |
| 2 | http://snomed.info/sct | 105721009 | General problem AND/OR complaint | Ada Keluhan  |

</div>
</div>
<br>
</details>
<!--END Part 6-1-->
</div>

### <div id="step7" style="font-weight: bold;">7. Diagnosis</div>

<div style="margin-left: 30px;">
<p>Data diagnosis pasien dapat dikirimkan menggunakan resource Condition. Informasi diagnosis yang dimiliki pasien dilaporkan menggunakan kode ICD-10. Satu payload Condition hanya dapat digunakan untuk melaporkan 1 kode ICD-10. Sehingga apabila pasien memiliki 2 diagnosis, maka dikirimkan 2 payload Condition dengan 2 kode ICD-10 yang berbeda.</p>

<!--Part 7-1 Variable Pencatatan Diagnosis-->
<details>
	<summary>
<h4>&#10133; Pencatatan Diagnosis</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-7-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-7-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-7-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-7-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-7-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Condition-Create-PencatatanDiagnosis}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-7-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Condition",
    "clinicalStatus": {
        "coding": [
            {
                "system": "http://terminology.hl7.org/CodeSystem/condition-clinical",
                "code": "active",
                "display": "Active"
            }
        ]
    },
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/condition-category",
                    "code": "encounter-diagnosis",
                    "display": "Encounter Diagnosis"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://hl7.org/fhir/sid/icd-10",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_VALUE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_VALUE&rcub;&rcub;</strong>"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "onsetDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_ONSET_DATETIME&rcub;&rcub;</strong>",
    "recordedDate": "<strong style="color:#00a7ff">&lcub;&lcub;CONDITION_RECORDED_DATETIME&rcub;&rcub;</strong>"
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-7-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      | &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __CONDITION_VALUE__           | Berisi data diagnosis menggunakan ICD-10 tahun 2010 |
| __CONDITION_ONSET_DATETIME__ | Tanggal perkiraan atau tanggal aktual atau tanggal-waktu kondisi mulai, menurut pendapat dokter.|
| __CONDITION_RECORDED_DATETIME__ | 	Tanggal kapan kondisi/keluhan ini tercatat dalam sistem (tanggal yang dibuat oleh sistem)|

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-7-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
</div>
<!--END Part 7-1-->

### <div id="step8" style="font-weight: bold;">8. Tindakan</div>

<div style="margin-left: 30px;">
<p>Tindakan yang dilaporkan dapat berupa tindakan non-invasif (konsultasi, edukasi) maupun invasif (contoh operasi). Standar kode tindakan/prosedur medis yang dikirimkan ke SATUSEHAT menggunakan kode ICD-9 CM.</p>

<!--Part 8-1 Variable Vaksinasi COVID-19-->
<details>
	<summary>
<h4>&#10133; Vaksinasi COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-8-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-8-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-8-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-8-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-8-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Condition-Create-PencatatanDiagnosis}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-8-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Procedure",
    "status": "completed",
    "category": {
        "coding": [
            {
                "system": "http://snomed.info/sct",
                "code": "107733003",
                "display": "Introduction procedure"
            }
        ],
        "text": "Introduction procedure"
    },
    "code": {
        "coding": [
            {
                "system": "http://hl7.org/fhir/sid/icd-9-cm",
                "code": "99.59",
                "display": "Other vaccination and inoculation"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "performedPeriod": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;PROCEDURE_PERIOD_START&rcub;&rcub;</strong>",
        "end": "<strong style="color:#00a7ff">&lcub;&lcub;PROCEDURE_PERIOD_END&rcub;&rcub;</strong>"
    },
    "performer": [
        {
            "actor": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
            }
        }
    ],
    "reasonCode": [
        {
            "coding": [
                {
                    "system": "http://hl7.org/fhir/sid/icd-10",
                    "code": "U11.9",
                    "display": "Need for immunization against COVID-19, unspecified"
                }
            ]
        }
    ],
    "bodySite": [
        {
            "coding": [
                {
                    "system": "http://snomed.info/sct",
                    "code": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_BODY_SITE&rcub;&rcub;</strong>",
                    "display": "<strong style="color:#00a7ff">&lcub;&lcub;VACCINE_BODY_SITE&rcub;&rcub;</strong>"
                }
            ]
        }
    ]
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-8-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __PATIENT_IHS_NUMBER__      | &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __ID_RESOURCE_ENCOUNTER__           | &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __PROCEDURE_PERIOD_START__           | Waktu mulai prosedur pasien dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz. |
| __PROCEDURE_PERIOD_END__           |  Waktu selesai prosedur pasien dengan tipe data dateTime, dengan format yang diperbolehkan YYYY-MM-DDThh:mm:ss+zz:zz. |
| __PRACTITIONER_IHS_NUMBER__ |  &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT|
| __VACCINE_BODY_SITE__ | Informasi detail dan lokasi anatomis dari pemberian tindakan, yang nilainya mengacu pada data terminologi SNOMED CT|

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-8-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
<br>
</details>
</div>
<!--END Part 8-1-->

<!--Part 9-1 Variable Pasien Pulang-->
### <div id="step9" style="font-weight: bold;">9. Update Kunjungan</div>

<div style="margin-left: 30px;">
<p>Setelah mendapatkan vaksinasi COVID-19, individu dapat pulang. Status kunjungan individu pada saat pulang direkam dengan menggunakan resource Encounter.</p>

<details>
	<summary>
		<h4>&#10133; Update Finished + Diagnosis</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-9-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-9-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-9-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-9-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<!-- Tab panes -->
<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-9-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid/vaksin/Encounter-Update-PasienPulang.json}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-9-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Encounter",
    "identifier":  [
        {
            "system": "http://sys-ids.kemkes.go.id/encounter/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "finished",
    "class": {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "AMB",
        "display": "ambulatory"
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>",
        "display": "<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_NAME&rcub;&rcub;</strong>"
    },
    "participant":  [
        {
            "type":  [
                {
                    "coding":  [
                        {
                            "system": "http://terminology.hl7.org/CodeSystem/v3-ParticipationType",
                            "code": "ATND",
                            "display": "attender"
                        }
                    ]
                }
            ],
            "individual": {
                "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DOCTOR_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "period": {
        "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
        "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
    },
    "location":  [
        {
            "location": {
                "reference": "Location/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_LOCATION&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_LOCATION_NAME&rcub;&rcub;</strong>"
            }
        }
    ],
    "diagnosis":  [
        {
            "condition": {
                "reference": "Condition/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_CONDITION&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;DIAGNOSIS_DISPLAY&rcub;&rcub;</strong>"
            },
            "use": {
                "coding":  [
                    {
                        "system": "http://terminology.hl7.org/CodeSystem/diagnosis-role",
                        "code": "DD",
                        "display": "Discharge diagnosis"
                    }
                ]
            },
            "rank": <strong style="color:#00a7ff">&lcub;&lcub;DIAGNOSIS_RANK&rcub;&rcub;</strong>
        }
    ],
    "statusHistory":  [
        {
            "status": "arrived",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        },
        {
            "status": "in-progress",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        },
        {
            "status": "finished",
            "period": {
                "start": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_START&rcub;&rcub;</strong>",
                "end": "<strong style="color:#00a7ff">&lcub;&lcub;ENCOUNTER_PERIOD1_END&rcub;&rcub;</strong>"
            }
        }
    ],
    "serviceProvider": {
        "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-9-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>

| Variabel                   | Deskripsi |
| ---------------------------| --------- |
| __ENCOUNTER_LOCAL_CODE__   | ID Lokal untuk Kunjungan/Encounter |
| __PATIENT_IHS_NUMBER__     | &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __PATIENT_NAME__           | Nama Pasien |
| __PRACTITIONER_IHS_NUMBER__      | &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __DOCTOR_NAME__            | Nama Dokter/Nakes |
| __ORGANIZATION_IHS_NUMBER__    | &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __ENCOUNTER_PERIOD1_START__| Waktu mulai/check-in kunjungan |
| __ENCOUNTER_PERIOD1_END__  | Waktu mulai/check-out kunjungan |
| __ID_RESOURCE_LOCATION__  | ID Location tempat kunjungan dilakukan |
| __ID_RESOURCE_CONDITION__  | Berisi satu atau lebih data diagnosis dari pasien. Diagnosa bisa berupa diagnosa awal dan/atau pulang dengan tipe data Reference, yang direferensikan ke data yang tersimpan di resource Condition. Di mana isi dari parameter {id-resource-Condition} adalah ID Condition yang didapatkan dari server. |
| __DIAGNOSIS_DISPLAY__  | Deskripsi diagnosis  |
| __DIAGNOSIS_RANK__  | Jika ada lebih dari 1 kondisi, maka gunakan elemen rank untuk mengurutkan mana diagnosa yang lebih utama. Semakin kecil angkanya, maka semakin utama, dengan tipe data positiveInt.  |
| __ENCOUNTER_LOCATION_NAME__| Nama Location tempat kunjungan dilakukan |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>
</div>

<div role="tabpanel" class="tab-pane" id="valueset-9-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<div>
[none]
</div>
</div>
</div>
</details>
<br>
<!--END Part 9-1-->
</div>
</div>


<!-- Deprecated Exmplanation

### <div id="step3" style="font-weight: bold;">3. Kategori & Subkategori Penerima Vaksin COVID-19</div>

<div style="margin-left: 30px;">

<details>
	<summary>
<h4>&#10133; Kategori Penerima Vaksin COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-3-1" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-3-1" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-3-1" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-3-1" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-3-1">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KelompokPenerima}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "survey",
                    "display": "Survey"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://terminology.kemkes.go.id/CodeSystem/clinical-term",
                "code": "OC000133",
                "display": "Kategori Penerima Vaksin COVID-19"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi, referensi ke value set "Kategori Kelompok Penerima Vaksin" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-3-1" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Kategori Kelompok Penerima Vaksin</div>

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | 223366009 | Healthcare professional | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 2 | OV000325 | Pelayan Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 3 | 105436006 | Elderly person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 4 | 133936004 | Adult | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 5 | 133937008 | Adolescent | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 6 | 410601007 | Childhood age person | [http://snomed.info/sct](http://snomed.info/sct)  |
| 7 | OV000326 | Diplomat | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 8 | OV000327 | Gotong Royong | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |



</div>
</div>
<br>
</details>

<details>
	<summary>
<h4>&#10133; Subkategori Penerima Vaksin COVID-19</h4>
	</summary>

<ul class="nav nav-tabs" role="tablist">
<li role="presentation" class="active">
<a href="#example-3-2" aria-controls="example" role="tab" data-toggle="tab">Example</a>
</li>
<li role="presentation">
<a href="#data-3-2" aria-controls="data" role="tab" data-toggle="tab">Template</a>
</li>
<li role="presentation">
<a href="#variabel-3-2" aria-controls="variabel" role="tab" data-toggle="tab">Placeholder Variable</a>
</li>
<li role="presentation">
<a href="#valueset-3-2" aria-controls="variabel" role="tab" data-toggle="tab">ValueSet</a>
</li>
</ul>

<div class="tab-content snippet">
<div role="tabpanel" class="tab-pane active" id="example-3-2">
<div style="background: #F6F8F8;border: 1px solid #e8edee;">
{{json:covid-vaksin-Observation-Create-KategoriPenerima}}
</div>
</div>

<div role="tabpanel" class="tab-pane" id="data-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">
<pre style="background: #F6F8F8;border: 1px solid #e8edee; color: maroon;">
{
    "resourceType": "Observation",
    "identifier": [
        {
            "system": "http://sys-ids.kemkes.go.id/observation/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>",
            "value": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_LOCAL_CODE&rcub;&rcub;</strong>"
        }
    ],
    "status": "final",
    "category": [
        {
            "coding": [
                {
                    "system": "http://terminology.hl7.org/CodeSystem/observation-category",
                    "code": "survey",
                    "display": "Survey"
                }
            ]
        }
    ],
    "code": {
        "coding": [
            {
                "system": "http://terminology.kemkes.go.id/CodeSystem/clinical-term",
                "code": "OC000134",
                "display": "Subkategori Penerima Vaksin COVID-19"
            }
        ]
    },
    "subject": {
        "reference": "Patient/<strong style="color:#00a7ff">&lcub;&lcub;PATIENT_IHS_NUMBER&rcub;&rcub;</strong>"
    },
    "encounter": {
        "reference": "Encounter/<strong style="color:#00a7ff">&lcub;&lcub;ID_RESOURCE_ENCOUNTER&rcub;&rcub;</strong>"
    },
    "effectiveDateTime": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_EFFECTIVE_DATETIME&rcub;&rcub;</strong>",
    "issued": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_ISSUED&rcub;&rcub;</strong>",
    "performer": [
        {
            "reference": "Practitioner/<strong style="color:#00a7ff">&lcub;&lcub;PRACTITIONER_IHS_NUMBER&rcub;&rcub;</strong>"
        },
        {
            "reference": "Organization/<strong style="color:#00a7ff">&lcub;&lcub;ORGANIZATION_IHS_NUMBER&rcub;&rcub;</strong>"
        }
    ],
    "valueCodeableConcept": {
        "coding": [
            {
                "system": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "code": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>",
                "display": "<strong style="color:#00a7ff">&lcub;&lcub;OBSERVATION_VALUE&rcub;&rcub;</strong>"
            }
        ]
    }
}
</pre>
</div>

<div role="tabpanel" class="tab-pane" id="variabel-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

| Variabel                       | Deskripsi |
| ------------------------------ | --------- |
| __ORGANIZATION_IHS_NUMBER__   			| &lcub;organization-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_LOCAL_CODE__    		| ID Lokal untuk Observasi  |
| __PATIENT_IHS_NUMBER__      			| &lcub;patient-ihs-number&rcub; pada SATUSEHAT |
| __ID_RESOURCE_ENCOUNTER__      		| &lcub;id-resource-Encounter&rcub; pada SATUSEHAT untuk data kunjungan |
| __OBSERVATION_EFFECTIVE_DATETIME__ 	| Tanggal dan waktu nilai observasi yang diamati dinyatakan benar |
| __OBSERVATION_ISSUED__ 				| Tanggal dan waktu versi observasi ini tersedia, biasanya setelah hasilnya ditinjau/direview dan diverifikasi|
| __PRACTITIONER_IHS_NUMBER__    				| &lcub;practitioner-ihs-number&rcub; pada SATUSEHAT |
| __OBSERVATION_VALUE__          		| __(*)__ Nilai observasi, referensi ke value set "Subkategori Kelompok Penerima Vaksin" |

> `CATATAN:` <br>
> __(*)__: Jenis data yang memiliki terminologi spesifik. Kamus terminologi bisa ditemukan pada tab "ValueSet"
</div>

<div role="tabpanel" class="tab-pane" id="valueset-3-2" style="border: 1px solid #e8edee; padding: 15px 10px;">

<div>Subkategori Kelompok Penerima Vaksin</div>

| No | Kode        | Display                | System|
|-|-|-|-|
| 1 | 410601007 | Childhood age person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 2 | 106325008 | Athlete, sportsman AND/OR related worker | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 3 | OV000328 | BUMD | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 4 | OV000329 | BUMN | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 5 | OV000330 | Disabilitas Lainnya | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 6 | OV000331 | Disabilitas Mental | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 7 | 255409004 | Pregnant woman | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 8 | OV000332 | Ibu Menyusui | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 9 | 308199006 | Security services occupation | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 10 | 105436006 | Elderly person | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 11 | OV000333 | Masyarakat Lainnya | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 12 | 417430008 | Vulnerable adult | [http://snomed.info/sct](http://snomed.info/sct)  |
| 13 | OV000334 | Masyarakat Umum | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 14 | OV000335 | Pariwisata | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 15 | OV000336 | Pedagang Pasar | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 16 | OV000337 | Pegawai Pemerintah | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 17 | OV000338 | Pejabat Negara | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 18 | OV000339 | Pelayan Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 19 | OV000340 | Pendamping Disabilitas | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 20 | OV000341 | Pendidik | http://terminology.kemkes.go.id/CodeSystem/clinical-term  |
| 21 | OV000342 | Penyuluh Agama | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 22 | 159465002 | Police/prison/fire officers | [http://snomed.info/sct](http://snomed.info/sct)  |
| 23 | OV000343 | Pra-Lansia | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 24 | 133937008 | Adolescent | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 25 | 223366009 | Healthcare professional | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 26 | 302314004 | Military personnel | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 27 | OV000344 | Transportasi Publik | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 28 | 428024001 | Clinical trial participant | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 29 | OV000345 | Wakil Rakyat | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |
| 30 | 51764002 | Reporter | [ ](http://snomed.info/sct)[http://snomed.info/sct](http://snomed.info/sct)  |
| 31 | OV000346 | WNA(PNA/OI) | [ ](http://terminology.kemkes.go.id/CodeSystem/clinical-term)[http://terminology.kemkes.go.id/CodeSystem/clinical-term](http://terminology.kemkes.go.id/CodeSystem/clinical-term)  |

</div>
</div>
<br>
</details>
</div>
-->